Page 1,691«..1020..1,6901,6911,6921,693..1,7001,710..»

The Politics of Stem Cells – Genome News Network

Posted: November 23, 2016 at 3:44 am

ome of the most exciting biomedical research of the 21st century isn't getting done. Research on stem cells from human embryos has become so entangled in politics and public misunderstanding that researchers are worried about serious delays in understanding life-threatening diseases.

Particularly in the United States, research involving human embryonic stem cells has slowed because of philosophical qualms, political opposition and confusion about the science. What's more, the field now seems treacherous for scientists, largely due to legislative uncertainties and restrictions on research from the White House.

"There are a lot of experiments that are obvious and would be extremely valuable for scientists to do," says Keith Yamamoto, vice dean for research at the University of California, San Francisco School of Medicine. "But it's too much work to put together a research proposal only to find out it's going to be made illegalor that there will be a four-year moratorium proposed."

President Bush declared in 2001 that scientists who receive federal research fundsby far the majoritycould work only with a handful of stem cell lines (those that were in existence before August 9, 2001). The White House said that more than 60 usable embryonic stem cell lines were available. But in reality the number is closer to nine.

To compound the problem, Congress has threatened to make it illegal to use cloning to create new stem cell lines for biomedical research. The possibility that Congress will outlaw the use of cloning technology to derive new cell lines is scaring researchers away, according to Yamamoto and other scientists.

Prospects seem dim that the controversiesand the uncertaintieswill be resolved anytime soon. However, one "research friendly" bill has been introduced in the Senate and has attracted support from an odd but important coalition of influential people. One of them is Nancy Reagan, whose husband, the former President, is in a late stage of Alzheimer's disease.

"I am determined to do what I can to save other families from this pain," she said in a letter, arguing in favor of stem-cell research with appropriate safeguards.

The opening days of the new Congress saw a virtual rerun of last year's fights. Over just the past few weeks:

-President Bush in his State of the Union address urged Congress to prohibit "all" human cloning "because no human life should be started or ended as the object of an experiment."

-Legislation was introduced in both House and Senate to ban the use of "somatic cell nuclear transfer"the cloning technique by which Dolly the sheep was producedto create a living human organism "at any stage of development." Within a few days of its introduction, the House bill had attracted more than 100 co-sponsors.

-A competing bill that would prohibit human reproductive cloning but would permit nuclear transfer to create embryonic stem cell lines for research was introduced in the Senate.

This latter, pro-research measure is cosponsored by an ideologically broad coalition, ranging from Diane Feinstein (D-CA) and Ted Kennedy (D-MA) to Zell Miller (D-GA) and Orrin Hatch (R-UT), whose right-to-life credentials are unassailable.

Essentially the same alignment of forces in the previous Congress produced a stalemate. The House passed a broad anti-cloning bill by a 265-162 vote in July 2001, but neither the broad prohibition nor a pro-research version came to a vote in the Senate because neither side could muster the 60 votes needed to shut down a Senate filibuster.

The most likely outcome now seems to be a continuing standoff unless members of Congress can learn the difference between using stem cells for research and using them for human reproduction.

Even if the Senate passed a pro-research bill, the House would be unlikely to agree. And even if such a bill made it through Congress, President Bush would likely veto it. The question of using somatic cell nuclear transfer to derive human embryonic stem cells involves an uncomfortable mix of science (including cell cloning), ethics and theology. It has not yet resulted in any useful compromise.

One of the stumbling blocks is a broad, deep lack of understanding of what the word "cloning" means. The word is widely used in our society and has been given a number of meanings, most of them wrong.

To scientists, cloning means making a copy of somethinganything, a stretch of DNA, a virus, a cell. To most laypeople, including many members of Congress, cloning means creating a carbon-copy organism, like Dolly the sheep or the army of clones in a recent "Star Wars" movie. It means making an exact copy of a living adult and the imagination often focuses on evil ones at that.

"We have to do a better job of educating the public that the word 'clone' is not synonymous with movies such as 'The Boys from Brazil' or 'The March of the Clones' or whatever else Hollywood has manufactured," says Nobel Laureate Paul Berg of Stanford University in California.

Opponents, such as President Bush and Leon Kass, chairman of the President's Council on Bioethics, believe that any use of somatic cell transfer could result in a human embryo, and thus a human life. "We find it disquieting, even somewhat ignoble, to treat what are in fact the seeds of the next generation as mere raw material for satisfying the needs of our own," a majority of Kass's council reported last July.

But proponents of this somatic cell technology deny that the technique produces the seeds of any generation. "I'm in favor of cloning nuclei in the form of stem cells," says Berg. "The product of that is not a human being." Some scientists and ethicists go so far as to argue that it is actually unethical not to do research that shows unusual promise for treating or preventing devastating disease.

Senator Hatch, whose influence as a conservative leader makes him an important player in the debate, argues that human life begins in the womb, not in a petri dish.

"Even those who believe that life begins at conception, even if the unison of sperm and egg takes place in the lab, need to consider carefully whether the joinder of an enucleated egg with a somatic cell nucleus, accompanied by chemical or electrical stimulation, should fairly be thought of as the same process as conception," Hatch told a Senate hearing in January.

Last July, Kass's bioethics council recommended a four-year moratorium on all research with somatic cell transfer if the intent is to produce human embryonic stem cells. Seven of the scientists on the Kass council voted against a moratorium; all of the ethicists voted in favor, as did one physician-scientist. Meanwhile, two separate committees of the National Academy of Sciences endorsed the research on grounds of its value to medicine.

Several states with ambitions to attract the biotechnology industry, including California and New Jersey, have tried to pass legislation of their own that would prohibit the use of cloning to make babies but would allow somatic cell nuclear transfer for scientific research.

In addition, some major research institutions, including Stanford and UCSF, have established satellite research centers that receive no federal funds to pursue such research. An outright federal prohibition would override these efforts.

A federal prohibition of all research to use this technology to create human embryonic stem cells also could erode one of the major potential benefits of stem cell science: the growth of replacement tissue such as cardiac muscle to repair heart damage, insulin-producing beta cells to cure type 1 diabetes, or dopamine-producing neurons to treat Parkinson's disease.

Theoretically, if a patient is his or her own donor of the somatic cell from which the embryonic stem cells would be grown, implanting the replacement tissue would raise no immunologic problems. This, clearly, has nothing to do with human reproduction.

The congressional standoff leaves would-be stem cell researchers with limited options. They can try to develop procedures with private industry or state fundingalthough that may eventually be prohibited. Or they can work with human embryonic stem cell lines derived from embryos originally created for in vitro fertilization (IVF) procedures.

This is where the president's moratorium of 2001 becomes an issue. A repertoire of nine cell lines with which to work is far different than 60 available cell lines. And because data suggest that none of those lines may be the best for use in medical experimentation, the need to develop new lines is imperative.

This amounts to a double whammy against stem cell research.

"At the present time, I don't think we have enough documented, usable cell lines to entice people into this field," says Berg.

James Battey, director of the National Institute on Deafness and Other Communication Disorders, who heads the National Institutes of Health's Stem Cell Task Force, contends that the restraints leave plenty of room for researchers.

"There's an enormous amount of basic research that can be done and needs to be done before anybody anticipates any clinical trials," Battey says.

Among the basic-research questions: How do you drive human embryonic stem cells to differentiate in a particular wayto be heart muscle or to produce dopamine in the brain, for instance? How do you then generate a pure population of the desired target cells? How do you assure that the cells will be long-lived? How do you prove, in animal models of disease, that they are effective therapies?

"All of these studies can be done right now, with human embryonic stem cell lines that you can order today on the NIH registry," Battey says.

Battey also challenges the contention that researchers are being scared away. At a meeting in London in January, however, he and research-funding officials from seven other nations agreed that a shortage of scientists trained to work with stem cells is a major problem. "That is probably the rate-limiting factor right now in moving the research agenda forwards," Battey says.

And political uncertainty is one of the reasons for the shortage. "These are careers," says Kevin Wilson, director of public policy for the American Society for Cell Biology, and vice president for legislative affairs of the Coalition for the Advancement of Medical Research. "Is a scientist going to get involved in a career field that could become against the law?"

As Wilson notes: "It's not a warm and fuzzy environment."

Read more:
The Politics of Stem Cells - Genome News Network

Posted in California Stem Cells | Comments Off on The Politics of Stem Cells – Genome News Network

Adoptive T Cell Therapy

Posted: November 23, 2016 at 3:44 am

It is a critical moment for adoptive T cell therapies. With numerous clinical trials ongoing, particularly with Chimeric Antigen Receptors, all eyes are on therapy developers for better or for worse. Despite the attention, the end goal is the same improved patient outcomes. Cambridge Healthtech Institutes Fourth Annual Adoptive T Cell Therapy event will focus on the steps needed to deliver adoptive cell therapies to the patient. Clinical progress with Chimeric Antigen Receptors (CAR), T Cell Receptors (TCR), and Tumor Infiltrating Lymphocytes (TIL) will be addressed in depth and new strategies for target discovery will be reviewed. Emphasis will also be placed on clinical case studies to further the understanding of T cell receptors and their biology. Additional focus will be given to manufacturing challenges and solutions for scale-up. Overall, this event will address clinical progress, case studies, and critical components to make adoptive T cell therapies viable.

Preliminary Agenda

Individualized Tumor Neoantigen-Based Vaccine Approaches to Cancer Therapy

Karin Jooss, Ph.D., CSO, Gritstone Oncology, Inc.

Discovery and Development of Novel Immunogenic Tumor Neoantigens for the Treatment of Solid Tumors

Philip Arlen, M.D., President and CEO, Precision Biologics, Inc.

How Can We Utilize Neoantigens in Personalized Therapies for Patients with Tumors Having Low Mutation Profiles?

Dolores Schendel, Ph.D., CEO and CSO, Medigene AG

Exploiting Natural Killer Receptors for CAR T Cell Therapy

David Gilham, Ph.D., Vice President, Research & Development, Celyad S.A.

Off-the-Shelf Cancer Immunotherapy: Engineered Pluripotent Cell-Derived Natural Killer Cells

Bahram (Bob) Valamehr, Ph.D., MBA, Executive Director, Reprogramming Biology and Cancer Immunotherapy, Fate Therapeutics, Inc.

ImmunoMap: A Novel Bioinformatics Tool to Visualize and Analyze T-Cell Receptor Repertoire Sequence Data

Jonathan Schneck, M.D., Ph.D., Professor, Pathology and Immunology, Johns Hopkins University

Overcoming CAR T-Cell Checkpoint Blockade in Solid Tumors

Prasad S. Adusumilli, M.D., F.A.C.S., Associate Attending and Deputy Chief, Thoracic Surgery, Memorial Sloan Kettering Cancer Center

New Targets in Hematologic Malignancies and Solid Tumors

J. Joseph Melenhorst, Ph.D., Director, Product Development and Correlative Sciences Laboratory, University of Pennsylvania

Adoptive Cell Therapy for Cancer Using Tumor Infiltrating Lymphocytes

John S. Bridgeman, Ph.D., Director, Cell Therapy Research, Cellular Therapeutics Ltd.

Enhancing Chimeric Antigen Receptor T Cell Therapy by Targeting Adenosine Mediated Immunosuppression

Paul Beavis, Ph.D., Senior Postdoctoral Researcher, Cancer Immunotherapy, Peter MacCallum Cancer Centre

New T-Cell Targets by Dissection of Successful Tumor-Infiltrating Lymphocyte Therapy for Melanoma

Andrew Sewell, Ph.D., Distinguished Research Professor and Wellcome Trust Senior Investigator, Cardiff University School of Medicine

ACTR: A Universal Approach to T Cell Therapy

Seth Ettenberg, Ph.D., CSO, Unum Therapeutics, Inc.

Continuously Growing NK Cell Line as a Source for an Off the Shelf, Engineered NK Cell Therapeutic in Cancer and Infections

Hans Klingemann, M.D., Ph.D., Vice President, Research & Development, NantKwest, Inc.

Off-the-Shelf CART Products

Dan Shoemaker, Ph.D., CSO, Fate Therapeutics, Inc.

For more details on the conference, please contact:

Samantha Drinkwater Senior Conference Director Cambridge Healthtech Institute Phone: 781-972-5461 E: sdrinkwater@healthtech.com

For partnering and sponsorship information, please contact:

Jason Gerardi (Companies A-K) Manager, Business Development Cambridge Healthtech Institute T: 781-972-5452 E: jgerardi@healthtech.com

Carol Dinerstein (Companies L-Z) Director, Business Development Cambridge Healthtech Institute T: 781-972-5471 E: dinerstein@healthtech.com

Read the rest here:
Adoptive T Cell Therapy

Posted in Cell Therapy | Comments Off on Adoptive T Cell Therapy

What Are Stem Cells? – Massachusetts General Hospital …

Posted: November 22, 2016 at 1:45 pm

Stem cells are unique in their ability to self-renew: to divide and create two cells, each identical to the original. Understanding stem cell self-renewal is central to understanding how organisms are made and maintained, and may lead to insights that permit physicians to modulate tissue regeneration and repair in their patients with chronic diseases.

Stem cells can also produce offspring that are more specialized (differentiated) than the parental cell. Directing the differentiation of stem cells into specialized cell types will enable cell replacement therapies. Replacing pancreatic beta cells in type I diabetics, or dopaminergic neurons in Parkinson's patients, are two possible examples. It is no accident that the spectacular advances in hematology depended in large part on the discovery and manipulation of blood stem cells, including the discovery of drugs that stimulate stem cell mobilization into the blood or enhance the differentiation of cells into mature blood cells. Moreover, intensive chemotherapy or irradiation for cancer is made possible by rescuing' the patient with an injection of blood stem cells. Because stem cell research is fundamentally about the ability to form, maintain and repair tissues, the insights gained from this research directly informs an understanding of abnormal processes such as cancer and degenerative disease.

There are two types of stem cells, adult stem cells and embryonic stem cells. Adult stem cells are found in mature tissues (bone marrow, skin, brain etc) that can self-renew and give rise to other cell types from their tissue of origin, thereby producing a steady supply of new cells to maintain that tissue throughout life. In general, adult stem cells from one organ do not give rise to cell types from other organs.

However, the embryonic stem (ES) cell warrants special attention as it is uniquely malleable and can make any part of the body. In some sense, ES cells represent the parent of all stem cells and provide a window into the first stages of the life. It is also important to note that mouse ES cells have precipitated a virtual revolution in our understanding of the relationship between genes and their function in intact animals. A close association of researchers working on ES cells and adult stem cells is critical to accelerate the understanding that will lead to stem cell therapies.

Back to Top

See the original post here:
What Are Stem Cells? - Massachusetts General Hospital ...

Posted in Massachusetts Stem Cells | Comments Off on What Are Stem Cells? – Massachusetts General Hospital …

New England Cord Blood Bank – Cord Blood and Cord Tissue …

Posted: November 22, 2016 at 1:45 pm

Prev

Peace Of Mind

By choosing to bank your babys cord blood with NECBB, you will preserve your familys chance to potentially use stem cells as a part of a treatment therapy for overeighty diseases, including various cancers, genetic diseases, blood disorders, and immune system deficiencies.

NECBB Ranked in Top Cord Blood Banks

Quality

We offer you the combination of experience, cutting-edge facilities, and integrity that ensures youre doing the best for your family by banking with such a trusted partner.

Clients First

NECBB is a family-owned company that believes strongly in putting clients first. We work with you to make the process as seamless as possible.

Affordability

Everyone who wishes to store cord blood should have the opportunity to do so, and that is why we work hard to keep costs down for you. Ask us about our payment plansand discounts for returning parents and multiple births!

Location

Weve moved to a new state-of-the-art facility in Marlborough, Massachusetts!

Experience

New England Cord Blood Bank is the worlds premier cord blood bank. Our unmatched experiencein cryogenics since 1971 and cord blood banking since 1995delivers the expertise and quality your family desires at an affordable price.

Complete this form for a FREE Downloadable comprehensive information packet, including everything you need to know about cord blood banking and about NECBB.

Its that time of year again; football, giving thanks, and the NECBB Black Friday Sale! Are you planning on enrollingto store your babys cord blood and segment? Do sobetweenNovember 25th and November 30th,and well give you free cord segment processing and first year segment storagea $400 savings!* Were you just planning on storing your childs []

Is it possible to delay cord clamping and still collect cord blood?The answer is yes. The recommended time for delaying cord clamping given by the World Health Organization is 1-3 minutes. Even ifclamping is delayed by 3 minutes, there will still be plenty ofblood remaining in the placenta and umbilical cord to collect.

Link:
New England Cord Blood Bank - Cord Blood and Cord Tissue ...

Posted in Massachusetts Stem Cells | Comments Off on New England Cord Blood Bank – Cord Blood and Cord Tissue …

Molecular Medicine | Molecular Medicine Reports …

Posted: November 20, 2016 at 7:47 am

Integrative Molecular Medicine (IMM) Online ISSN: 2056-6360 University College London Cancer Treatment Centers of America

Integrative Molecular Medicine (IMM) is a peer-reviewed, online open access journal dedicated to a new research discipline at the interface between clinical research and basic biology. We aim to publish articles that broadly enlighten the biomedicine research community by providing an insight on breakthrough discoveries in basic and clinical medicinal research, thereby lending a strong impetus to this important and rapidly developing field and helping to forge new links between clinicians and molecular biologists. Integrative Molecular Medicine highlights ongoing integrative basic and clinical biomedicines covering fields of biology and medicine.As such the following qualities are essential in any article published by the journal: scientific credibility and rigour, and coherence and clarity in the writing. Contributions do not need to be novel as confirmatory and replication studies will be considered, however the article must present new findings, which could include the reporting of negative findings.

IMM provides a new platform for all researchers, scientists, scholars, students to publish their research work and update the latest research information.Integrative Molecular Medicine publishes research articles as full-length research papers and short reports. In addition, the journal publishes editorials and review articles in innovative formats that target a broad and non-specialized audience.

Journal will accept article from the following topics are integrative medical fields including biochemistry, molecular and cell biology, biotechnology, genetics, physiology, endocrinology, signal transduction, cell proliferation, differentiation and development, stem cells and regenerative medicine apoptosis, gene expression, pathology, metabolic disease, genomics, transcriptomics, proteomics, metabolomics of disease, systems medicine, brain disease, cardiovascular biology, diabetes, obesity, osteoporosis, nutrition, pharmacology, toxicology, cancer biology and oncology, epidemiology, genetic medicine, and other medicine-related topics.

IMM welcomes direct submissions of manuscripts from authors. You can submit your manuscript to: submissions@oatext.com; alternatively to: yamaguchi@oatext.com

I graduated as an MD at Lviv State Medical University (Ukraine) in 1983 with a great passion to become a surgeon in oncology. Thinking that a PhD in experimental oncology would help to realize my dream, I obtained my doctorate at the Institute of Experimental Oncology, National Academy of Sciences of Ukraine in 1987. A fellowship from the International Agency for Research on Cancer (IARC) took me even further from clinical oncology and also from Ukraine. I arrived in London on the first wave of perestroika and began my post-doctoral training in Jim Woodgett's laboratory at the Ludwig Institute for Cancer Research (UCL Branch). Subsequently, I worked in Mike Waterfield's laboratory at the same Institute studying signal transduction via the PI3 kinase pathway. In 1996, I started my own group at the Ludwig Institute for Cancer Research, focusing on the regulation of growth via the S6 kinase pathway. Since 2003, I have been a Professor in the Department of Biochemistry at UCL now renamed Structural and Molecular Biology, where I have an active research group working on signal transduction and cellular metabolism in health and disease. I have a strong research (113 papers in peer-reviewed journals, H-Index 52) and patent (10 world-wide patents) portfolio and run two drug discovery programs aimed at developing small molecule inhibitors, targeting ribosomal S6 kinase and Aurora A kinase.

Dr. Alvarez, a native of Argentina, joined CTCA in October 2014 to lead the companys global focus on cancer research. He is internationally known for his contribution to breast cancer multidisciplinary management, inflammatory breast cancer, and discovery and monitoring of minimal residual disease in solid tumors. As a medical oncologist, he has focused his clinical career the past two decades on treating patients with the most difficult cases of breast cancer. Prior to joining CTCA, Dr. Alvarez served for five years as an Assistant Professor in the University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology, Division of Cancer Medicine in Houston, Tx. He also served as Assistant Professor at The Morgan Welch Inflammatory Breast Cancer Research Program. His additional experience includes teaching at the Department of Pathology and the Department of Internal Medicine, Universidad Nacional de La Plata, Argentina. He served as Chief, Oncology Section, Hospital Ramon Carrillo - San Carlos de Bariloche, Rio Negro, Argentina, and Instructor, Oncology Consultants P.A., Houston, Tx. He was Secretary of Clinical Oncology Section, School of Oncology, Fundacion Jose Maria Mainetti, Centro Oncologico de Excelencia, Gonnet, Argentina; and Member, Centro Oncologico de Excelencia, Gonnet.

Dr. Alvarez received his medical degree from Universidad Nacional de La Plata - Facultad de Medicina, Argentina. He completed his residency in internal medicine and medical oncology at Centro Oncologico de Excelencia - Gonnet, Argentina. Following completion of his medical oncology training, he pursued additional training in Clinical Pathology to further study molecular diagnostic and serve as Instructor at the Pathology Department with Dr. Pedro Laguens at the Universidad Nacional de La Plata. He also participated in multiple research activities and attended multiple grand rounds with Professors Jose Maria Mainetti and Alberto Luchina, and with several others became leaders in Argentinean oncology. Following his training in Argentina, he moved to Houston to pursue a medical residency in internal medicine at The University of Texas at Houston, and completed a fellowship in hematology and oncology at The University of Texas MD Anderson Cancer Center, Houston, TX. He earned a masters degree in cancer biology from the Graduate School of Biomedical Sciences at Houston. Dr. Alvarez has received numerous professional awards for his work in cancer research, including T-32 NIH CA009666 in 2006, Award of Excellence in Cancer Research by Texas Medical Society of Oncology in 2008, and the Susan Papizan Dolan Fellowship in Breast Cancer Research in 2008. He has participated in nearly $5 million in research grants and contracts with multiple clinical studies, including several Phase II Investigator Initiated Studies, since 2009 alone.

In 2014, he was Principal Investigator in a study related to monitoring minimal residual disease in locally advanced breast cancer and inflammatory breast cancer by detecting circulating tumor cells. The goal of this study, funded by Sister Institution Fund Network as part of the Global Academy Program Department at MD Anderson, is to identify molecular markers of breast cancer tumor recurrence. This clinical trial is currently active in the U.S., as well as in five academic Institutions across the world, including: INCan in Mexico, INEM in Peru, Clnica Alemana in Santiago de Chile, Barretos Hosptial in Brasil, and University of Oslo in Norway. Dr. Alvarez has authored more than 50 articles, abstracts and book chapters and is a frequent presenter at international oncology conferences. His professional memberships include: American Society of Clinical Oncology (ASCO,) American College of Physicians (ACP), American Society of Hematology (ASH), American Association of Cancer Research (AACR), and the Society of Clinical Research Associates (SOCRA). He was a founding member of Grupo de Estudio Tratamiento e Investigacion del Cancer del Sur (GETICS) in Argentina in 1996.

Hiromichi Nakadate Evrim Kurtoglu Shota Shirasaki Shigeru Aomura

Research Article-Integrative Molecular Medicine (IMM)

August 06, 2016

Taishi Koganemaru Koji Hori Misa Hosoi Kimiko Konishi Mitsugu Hachisu Hiroi Tomioka Masayuki Tani Yuka Kitajima Atsuko Inamoto

Case Report-Integrative Molecular Medicine (IMM)

August 09, 2016

Margaret Simonian

Editorial-Integrative Molecular Medicine (IMM)

August 09, 2016

Koji Wakame Akifumi Nakata Keisuke Sato Takehito Miura Anil.D.Kulkarni Marie-Francoise Doursout Alamelu Sundersan Ken-Ich Komatsu

Research Article-Integrative Molecular Medicine (IMM)

August 10, 2016

Veronica J. James Mark McGovern Peihong Wu Boyang Chang Yankeng Wu

Mini Review-Integrative Molecular Medicine (IMM)

August 18, 2016

Josh Hiller Celeste Vallejo Leo Betthauser James Keesling

Research Article-Integrative Molecular Medicine (IMM)

August 19, 2016

Gregory Lee

Research Article-Integrative Molecular Medicine (IMM)

August 25, 2016

Yoko Takai Asuka Matsuo Zhiwei Qiao Tadashi Kondo

Research Article-Integrative Molecular Medicine (IMM)

August 26, 2016

Oxenkrug G Cornicelli J van der Hart M Roeser J Summergrad P

Research Article-Integrative Molecular Medicine (IMM)

August 29, 2016

Cristina Daneri-Becerra Mario D. Galigniana

Research Article-Integrative Molecular Medicine (IMM)

August 22, 2016

Nepton Sheik Khoni GhazalehShoja E Razavi Himakshi Sharma

Research Article-Integrative Molecular Medicine (IMM)

August 22, 2016

Charles J. Malemud

Research Article-Integrative Molecular Medicine (IMM)

September 05, 2016

Nepton Sheik Khoni Abdul Rahman El Kinge Abdul Rahman El Kinge

Perspective-Integrative Molecular Medicine (IMM)

August 30, 2016

Akio Sugitachi Naoko Takahashi Yoshimori Takamori

Research Article-Integrative Molecular Medicine (IMM)

May 12, 2016

Alexander P Lykov Elena P Trifonova Olga V Sazonova Elena V Zonova

Research Article-Integrative Molecular Medicine (IMM)

May 14, 2016

Shigeru Aomura Hiromichi Nakadate Yuma Kaneko Akiyoshi Nishimura Remy Willinger

Research Article-Integrative Molecular Medicine (IMM)

May 18, 2016

Mitsumi Arito Hiroyuki Mitsui Manae S Kurokawa Kazuo Yudoh Toshikazu Kamada Hisateru Niki Tomohiro Kato

Research Article-Integrative Molecular Medicine (IMM)

May 26, 2016

Zen Kouchi

Research Article-Integrative Molecular Medicine (IMM)

May 27, 2016

Yoshimitsu Kiriyama Kunihiko Kasai Katsuhito Kino Hiromi Nochi

Research Article-Integrative Molecular Medicine (IMM)

June 10, 2016

Hisako Nakagawa Tadaaki Miyazaki

Research Article-Integrative Molecular Medicine (IMM)

June 13, 2016

Yoshikazu Hirasawa Hisayo Yokoyama Nooshin Naghavi Yoshihiro Yamashina Ryosuke Takeda Akemi Ota Daiki Imai Tomoaki Morioka Masanori Emoto Kazunobu Okazaki

Research Article-Integrative Molecular Medicine (IMM)

June 17, 2016

Toshihisa Ishikawa Masaharu Shinkai Takeshi Kaneko

Mini Review-Integrative Molecular Medicine (IMM)

June 22, 2016

Osman A Hamour Eman M.Fallatah Rawan O. Alshehri Zain A. Alshareef Halah F.AL-Enizi

Research Article-Integrative Molecular Medicine (IMM)

June 23, 2016

Kazuyuki Matsushima Mika Suematsu Chie Mifude Kuniyoshi Kaseda

Research Article-Integrative Molecular Medicine (IMM)

June 24, 2016

A. Espinosa-Jeffrey R. A. Arrazola B. Chu A. Taniguchi S. M. Barajas P. Bokhoor J. Garcia A. Feria-Velasco J. de Vellis

Research Article-Integrative Molecular Medicine (IMM)

June 25, 2016

Edna Aurelus

Research Article-Integrative Molecular Medicine (IMM)

July 07, 2016

Estela S. Estap

Commentary-Integrative Molecular Medicine (IMM)

July 07, 2016

Ricardo H. Alvarez Cancer Treatment Centers of America

Submission date: November 30, 2016 Publication date: January 31, 2017

Editor Affiliation: David W. Moskowitz MD FACP, Founder and CEO, GenoMed, Inc. (www.genomed.com)

Submission date: June 30, 2016 Publication date: August 03, 2016

Description of the Special Issue: It's widely agreed that molecular medicine will revolutionize the practice of medicine. Few people realize that it's long overdue. Linus Pauling and colleagues published "Sickle Cell Anemia, a Molecular Disease," in the November 1949 issue of Science, but the treatment for sickle cell disease remains unsatisfactory over 65 years later.

What has been holding up the medical revolution? Papers are solicited on this general topic. They may address any of the following topics, or another that the author feels is equally important:

1. Problems solving polygenic diseases 2. Is there a better approach to oncology? 3. Drug discovery and development in the 21st century 4. Shifting the healthcare industry to prevention: economic and legal challenges 5. The role of public health authorities 6. The role of the media 7. The role of investors

View original post here:
Molecular Medicine | Molecular Medicine Reports ...

Posted in Molecular Medicine | Comments Off on Molecular Medicine | Molecular Medicine Reports …

LSUHSC School of Medicine – Biochemistry and Molecular Biology

Posted: November 20, 2016 at 7:47 am

The Department of Biochemistry and Molecular Biology is an integral part of the LSU Health in New Orleans, which includes the Schools of Allied Health, Dentistry, Graduate Studies, Medicine, and Nursing. The faculty within the Department have strong, diverse research interests including cancer molecular and cellular biology, neuropeptide and enzyme processing, protein biochemistry, gene promoter and expression analyses, molecular biology of aging, cardiac development, cancer genetics, and molecular epidemiology of cancer. The Department offers PhD and MD/PhD degrees. Students, postdoctoral research scientists, research faculty, and visiting faculty members make significant contributions to the Department's activities. Strong collaborations exist with Basic Science and Clinical researchers within the LSUHealth community, with research groups elsewhere on a national and international level, and with established and emerging biotechnology industry.

The Department is well-equipped with most modern biochemical equipment required for the analysis of nucleic acids and proteins, including a state-of-the-art microarray core, a DNA sequencing core, and preparative ultracentrifuges. The Department is also equipped with facilities for high-pressure liquid chromatography, fast protein liquid chromatography, fluorescent in situ hybridization, fluorescent activated cell sorting, and microinjection. The Health Sciences Center Core Laboratories contain facilities for oligonucleotide synthesis, peptide synthesis and microsequencing, mass spectroscopy, a fluorescence-activated cell sorter, and a phosphorimager. An Image Analysis facility includes a confocal microscope as well as a molecular modeling workstation.

The shop facilities of the Department contain all of the equipment needed for fabrication and repair of scientific equipment.

Together with the Neuroscience Center, the Department administers an extensive tissue culture facility, which provides sterile media preparation, long-term storage of cell lines in liquid nitrogen, and propagates cell lines. More than 100 cell lines are contained within the tissue culture liquid nitrogen banks.

In addition to its on-site library facilities, the Health Sciences Center belongs to a library consortium which provides inter-library loans of books and journals.

Sincerely, Arthur L. Haas, PhD Professor and Chairman

Continued here:
LSUHSC School of Medicine - Biochemistry and Molecular Biology

Posted in Molecular Medicine | Comments Off on LSUHSC School of Medicine – Biochemistry and Molecular Biology

Gene therapy – Wikipedia

Posted: November 20, 2016 at 7:46 am

Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease.[1] The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful and approved[by whom?] nuclear gene transfer in humans was performed in May 1989.[2] The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.

Between 1989 and February 2016, over 2,300 clinical trials had been conducted, more than half of them in phase I.[3]

It should be noted that not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients.[4] Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effects.

Gene therapy was conceptualized in 1972, by authors who urged caution before commencing human gene therapy studies.

The first attempt, an unsuccessful one, at gene therapy (as well as the first case of medical transfer of foreign genes into humans not counting organ transplantation) was performed by Martin Cline on 10 July 1980.[5][6] Cline claimed that one of the genes in his patients was active six months later, though he never published this data or had it verified[7] and even if he is correct, it's unlikely it produced any significant beneficial effects treating beta-thalassemia.[8]

After extensive research on animals throughout the 1980s and a 1989 bacterial gene tagging trial on humans, the first gene therapy widely accepted as a success was demonstrated in a trial that started on September 14, 1990, when Ashi DeSilva was treated for ADA-SCID.[9]

The first somatic treatment that produced a permanent genetic change was performed in 1993.[10]

This procedure was referred to sensationally and somewhat inaccurately in the media as a "three parent baby", though mtDNA is not the primary human genome and has little effect on an organism's individual characteristics beyond powering their cells.

Gene therapy is a way to fix a genetic problem at its source. The polymers are either translated into proteins, interfere with target gene expression, or possibly correct genetic mutations.

The most common form uses DNA that encodes a functional, therapeutic gene to replace a mutated gene. The polymer molecule is packaged within a "vector", which carries the molecule inside cells.

Early clinical failures led to dismissals of gene therapy. Clinical successes since 2006 regained researchers' attention, although as of 2014, it was still largely an experimental technique.[11] These include treatment of retinal diseases Leber's congenital amaurosis[12][13][14][15] and choroideremia,[16]X-linked SCID,[17] ADA-SCID,[18][19]adrenoleukodystrophy,[20]chronic lymphocytic leukemia (CLL),[21]acute lymphocytic leukemia (ALL),[22]multiple myeloma,[23]haemophilia[19] and Parkinson's disease.[24] Between 2013 and April 2014, US companies invested over $600 million in the field.[25]

The first commercial gene therapy, Gendicine, was approved in China in 2003 for the treatment of certain cancers.[26] In 2011 Neovasculgen was registered in Russia as the first-in-class gene-therapy drug for treatment of peripheral artery disease, including critical limb ischemia.[27] In 2012 Glybera, a treatment for a rare inherited disorder, became the first treatment to be approved for clinical use in either Europe or the United States after its endorsement by the European Commission.[11][28]

Following early advances in genetic engineering of bacteria, cells, and small animals, scientists started considering how to apply it to medicine. Two main approaches were considered replacing or disrupting defective genes.[29] Scientists focused on diseases caused by single-gene defects, such as cystic fibrosis, haemophilia, muscular dystrophy, thalassemia and sickle cell anemia. Glybera treats one such disease, caused by a defect in lipoprotein lipase.[28]

DNA must be administered, reach the damaged cells, enter the cell and express/disrupt a protein.[30] Multiple delivery techniques have been explored. The initial approach incorporated DNA into an engineered virus to deliver the DNA into a chromosome.[31][32]Naked DNA approaches have also been explored, especially in the context of vaccine development.[33]

Generally, efforts focused on administering a gene that causes a needed protein to be expressed. More recently, increased understanding of nuclease function has led to more direct DNA editing, using techniques such as zinc finger nucleases and CRISPR. The vector incorporates genes into chromosomes. The expressed nucleases then knock out and replace genes in the chromosome. As of 2014 these approaches involve removing cells from patients, editing a chromosome and returning the transformed cells to patients.[34]

Gene editing is a potential approach to alter the human genome to treat genetic diseases,[35] viral diseases,[36] and cancer.[37] As of 2016 these approaches were still years from being medicine.[38][39]

Gene therapy may be classified into two types:

In somatic cell gene therapy (SCGT), the therapeutic genes are transferred into any cell other than a gamete, germ cell, gametocyte or undifferentiated stem cell. Any such modifications affect the individual patient only, and are not inherited by offspring. Somatic gene therapy represents mainstream basic and clinical research, in which therapeutic DNA (either integrated in the genome or as an external episome or plasmid) is used to treat disease.

Over 600 clinical trials utilizing SCGT are underway in the US. Most focus on severe genetic disorders, including immunodeficiencies, haemophilia, thalassaemia and cystic fibrosis. Such single gene disorders are good candidates for somatic cell therapy. The complete correction of a genetic disorder or the replacement of multiple genes is not yet possible. Only a few of the trials are in the advanced stages.[40]

In germline gene therapy (GGT), germ cells (sperm or eggs) are modified by the introduction of functional genes into their genomes. Modifying a germ cell causes all the organism's cells to contain the modified gene. The change is therefore heritable and passed on to later generations. Australia, Canada, Germany, Israel, Switzerland and the Netherlands[41] prohibit GGT for application in human beings, for technical and ethical reasons, including insufficient knowledge about possible risks to future generations[41] and higher risks versus SCGT.[42] The US has no federal controls specifically addressing human genetic modification (beyond FDA regulations for therapies in general).[41][43][44][45]

The delivery of DNA into cells can be accomplished by multiple methods. The two major classes are recombinant viruses (sometimes called biological nanoparticles or viral vectors) and naked DNA or DNA complexes (non-viral methods).

In order to replicate, viruses introduce their genetic material into the host cell, tricking the host's cellular machinery into using it as blueprints for viral proteins. Scientists exploit this by substituting a virus's genetic material with therapeutic DNA. (The term 'DNA' may be an oversimplification, as some viruses contain RNA, and gene therapy could take this form as well.) A number of viruses have been used for human gene therapy, including retrovirus, adenovirus, lentivirus, herpes simplex, vaccinia and adeno-associated virus.[3] Like the genetic material (DNA or RNA) in viruses, therapeutic DNA can be designed to simply serve as a temporary blueprint that is degraded naturally or (at least theoretically) to enter the host's genome, becoming a permanent part of the host's DNA in infected cells.

Non-viral methods present certain advantages over viral methods, such as large scale production and low host immunogenicity. However, non-viral methods initially produced lower levels of transfection and gene expression, and thus lower therapeutic efficacy. Later technology remedied this deficiency[citation needed].

Methods for non-viral gene therapy include the injection of naked DNA, electroporation, the gene gun, sonoporation, magnetofection, the use of oligonucleotides, lipoplexes, dendrimers, and inorganic nanoparticles.

Some of the unsolved problems include:

Three patients' deaths have been reported in gene therapy trials, putting the field under close scrutiny. The first was that of Jesse Gelsinger in 1999.[52] One X-SCID patient died of leukemia in 2003.[9] In 2007, a rheumatoid arthritis patient died from an infection; the subsequent investigation concluded that the death was not related to gene therapy.[53]

In 1972 Friedmann and Roblin authored a paper in Science titled "Gene therapy for human genetic disease?"[54] Rogers (1970) was cited for proposing that exogenous good DNA be used to replace the defective DNA in those who suffer from genetic defects.[55]

In 1984 a retrovirus vector system was designed that could efficiently insert foreign genes into mammalian chromosomes.[56]

The first approved gene therapy clinical research in the US took place on 14 September 1990, at the National Institutes of Health (NIH), under the direction of William French Anderson.[57] Four-year-old Ashanti DeSilva received treatment for a genetic defect that left her with ADA-SCID, a severe immune system deficiency. The effects were temporary, but successful.[58]

Cancer gene therapy was introduced in 1992/93 (Trojan et al. 1993).[59] The treatment of glioblastoma multiforme, the malignant brain tumor whose outcome is always fatal, was done using a vector expressing antisense IGF-I RNA (clinical trial approved by NIH n 1602, and FDA in 1994). This therapy also represents the beginning of cancer immunogene therapy, a treatment which proves to be effective due to the anti-tumor mechanism of IGF-I antisense, which is related to strong immune and apoptotic phenomena.

In 1992 Claudio Bordignon, working at the Vita-Salute San Raffaele University, performed the first gene therapy procedure using hematopoietic stem cells as vectors to deliver genes intended to correct hereditary diseases.[60] In 2002 this work led to the publication of the first successful gene therapy treatment for adenosine deaminase-deficiency (SCID). The success of a multi-center trial for treating children with SCID (severe combined immune deficiency or "bubble boy" disease) from 2000 and 2002, was questioned when two of the ten children treated at the trial's Paris center developed a leukemia-like condition. Clinical trials were halted temporarily in 2002, but resumed after regulatory review of the protocol in the US, the United Kingdom, France, Italy and Germany.[61]

In 1993 Andrew Gobea was born with SCID following prenatal genetic screening. Blood was removed from his mother's placenta and umbilical cord immediately after birth, to acquire stem cells. The allele that codes for adenosine deaminase (ADA) was obtained and inserted into a retrovirus. Retroviruses and stem cells were mixed, after which the viruses inserted the gene into the stem cell chromosomes. Stem cells containing the working ADA gene were injected into Andrew's blood. Injections of the ADA enzyme were also given weekly. For four years T cells (white blood cells), produced by stem cells, made ADA enzymes using the ADA gene. After four years more treatment was needed.[citation needed]

Jesse Gelsinger's death in 1999 impeded gene therapy research in the US.[62][63] As a result, the FDA suspended several clinical trials pending the reevaluation of ethical and procedural practices.[64]

The modified cancer gene therapy strategy of antisense IGF-I RNA (NIH n 1602)[65] using antisense / triple helix anti IGF-I approach was registered in 2002 by Wiley gene therapy clinical trial - n 635 and 636. The approach has shown promising results in the treatment of six different malignant tumors: glioblastoma, cancers of liver, colon, prostate, uterus and ovary (Collaborative NATO Science Programme on Gene Therapy USA, France, Poland n LST 980517 conducted by J. Trojan) (Trojan et al., 2012). This antigene antisense/triple helix therapy has proven to be efficient, due to the mechanism stopping simultaneously IGF-I expression on translation and transcription levels, strengthening anti-tumor immune and apoptotic phenomena.

Sickle-cell disease can be treated in mice.[66] The mice which have essentially the same defect that causes human cases used a viral vector to induce production of fetal hemoglobin (HbF), which normally ceases to be produced shortly after birth. In humans, the use of hydroxyurea to stimulate the production of HbF temporarily alleviates sickle cell symptoms. The researchers demonstrated this treatment to be a more permanent means to increase therapeutic HbF production.[67]

A new gene therapy approach repaired errors in messenger RNA derived from defective genes. This technique has the potential to treat thalassaemia, cystic fibrosis and some cancers.[68]

Researchers created liposomes 25 nanometers across that can carry therapeutic DNA through pores in the nuclear membrane.[69]

In 2003 a research team inserted genes into the brain for the first time. They used liposomes coated in a polymer called polyethylene glycol, which, unlike viral vectors, are small enough to cross the bloodbrain barrier.[70]

Short pieces of double-stranded RNA (short, interfering RNAs or siRNAs) are used by cells to degrade RNA of a particular sequence. If a siRNA is designed to match the RNA copied from a faulty gene, then the abnormal protein product of that gene will not be produced.[71]

Gendicine is a cancer gene therapy that delivers the tumor suppressor gene p53 using an engineered adenovirus. In 2003, it was approved in China for the treatment of head and neck squamous cell carcinoma.[26]

In March researchers announced the successful use of gene therapy to treat two adult patients for X-linked chronic granulomatous disease, a disease which affects myeloid cells and damages the immune system. The study is the first to show that gene therapy can treat the myeloid system.[72]

In May a team reported a way to prevent the immune system from rejecting a newly delivered gene.[73] Similar to organ transplantation, gene therapy has been plagued by this problem. The immune system normally recognizes the new gene as foreign and rejects the cells carrying it. The research utilized a newly uncovered network of genes regulated by molecules known as microRNAs. This natural function selectively obscured their therapeutic gene in immune system cells and protected it from discovery. Mice infected with the gene containing an immune-cell microRNA target sequence did not reject the gene.

In August scientists successfully treated metastatic melanoma in two patients using killer T cells genetically retargeted to attack the cancer cells.[74]

In November researchers reported on the use of VRX496, a gene-based immunotherapy for the treatment of HIV that uses a lentiviral vector to deliver an antisense gene against the HIV envelope. In a phase I clinical trial, five subjects with chronic HIV infection who had failed to respond to at least two antiretroviral regimens were treated. A single intravenous infusion of autologous CD4 T cells genetically modified with VRX496 was well tolerated. All patients had stable or decreased viral load; four of the five patients had stable or increased CD4 T cell counts. All five patients had stable or increased immune response to HIV antigens and other pathogens. This was the first evaluation of a lentiviral vector administered in a US human clinical trial.[75][76]

In May researchers announced the first gene therapy trial for inherited retinal disease. The first operation was carried out on a 23-year-old British male, Robert Johnson, in early 2007.[77]

Leber's congenital amaurosis is an inherited blinding disease caused by mutations in the RPE65 gene. The results of a small clinical trial in children were published in April.[12] Delivery of recombinant adeno-associated virus (AAV) carrying RPE65 yielded positive results. In May two more groups reported positive results in independent clinical trials using gene therapy to treat the condition. In all three clinical trials, patients recovered functional vision without apparent side-effects.[12][13][14][15]

In September researchers were able to give trichromatic vision to squirrel monkeys.[78] In November 2009, researchers halted a fatal genetic disorder called adrenoleukodystrophy in two children using a lentivirus vector to deliver a functioning version of ABCD1, the gene that is mutated in the disorder.[79]

An April paper reported that gene therapy addressed achromatopsia (color blindness) in dogs by targeting cone photoreceptors. Cone function and day vision were restored for at least 33 months in two young specimens. The therapy was less efficient for older dogs.[80]

In September it was announced that an 18-year-old male patient in France with beta-thalassemia major had been successfully treated.[81] Beta-thalassemia major is an inherited blood disease in which beta haemoglobin is missing and patients are dependent on regular lifelong blood transfusions.[82] The technique used a lentiviral vector to transduce the human -globin gene into purified blood and marrow cells obtained from the patient in June 2007.[83] The patient's haemoglobin levels were stable at 9 to 10 g/dL. About a third of the hemoglobin contained the form introduced by the viral vector and blood transfusions were not needed.[83][84] Further clinical trials were planned.[85]Bone marrow transplants are the only cure for thalassemia, but 75% of patients do not find a matching donor.[84]

Cancer immunogene therapy using modified anti gene, antisense / triple helix approach was introduced in South America in 2010/11 in La Sabana University, Bogota (Ethical Committee 14.12.2010, no P-004-10). Considering the ethical aspect of gene diagnostic and gene therapy targeting IGF-I, the IGF-I expressing tumors i.e. lung and epidermis cancers, were treated (Trojan et al. 2016). [86][87]

In 2007 and 2008, a man was cured of HIV by repeated Hematopoietic stem cell transplantation (see also Allogeneic stem cell transplantation, Allogeneic bone marrow transplantation, Allotransplantation) with double-delta-32 mutation which disables the CCR5 receptor. This cure was accepted by the medical community in 2011.[88] It required complete ablation of existing bone marrow, which is very debilitating.

In August two of three subjects of a pilot study were confirmed to have been cured from chronic lymphocytic leukemia (CLL). The therapy used genetically modified T cells to attack cells that expressed the CD19 protein to fight the disease.[21] In 2013, the researchers announced that 26 of 59 patients had achieved complete remission and the original patient had remained tumor-free.[89]

Human HGF plasmid DNA therapy of cardiomyocytes is being examined as a potential treatment for coronary artery disease as well as treatment for the damage that occurs to the heart after myocardial infarction.[90][91]

In 2011 Neovasculgen was registered in Russia as the first-in-class gene-therapy drug for treatment of peripheral artery disease, including critical limb ischemia; it delivers the gene encoding for VEGF.[92][27] Neovasculogen is a plasmid encoding the CMV promoter and the 165 amino acid form of VEGF.[93][94]

The FDA approved Phase 1 clinical trials on thalassemia major patients in the US for 10 participants in July.[95] The study was expected to continue until 2015.[96]

In July 2012, the European Medicines Agency recommended approval of a gene therapy treatment for the first time in either Europe or the United States. The treatment used Alipogene tiparvovec (Glybera) to compensate for lipoprotein lipase deficiency, which can cause severe pancreatitis.[97] The recommendation was endorsed by the European Commission in November 2012[11][28][98][99] and commercial rollout began in late 2014.[100]

In December 2012, it was reported that 10 of 13 patients with multiple myeloma were in remission "or very close to it" three months after being injected with a treatment involving genetically engineered T cells to target proteins NY-ESO-1 and LAGE-1, which exist only on cancerous myeloma cells.[23]

In March researchers reported that three of five subjects who had acute lymphocytic leukemia (ALL) had been in remission for five months to two years after being treated with genetically modified T cells which attacked cells with CD19 genes on their surface, i.e. all B-cells, cancerous or not. The researchers believed that the patients' immune systems would make normal T-cells and B-cells after a couple of months. They were also given bone marrow. One patient relapsed and died and one died of a blood clot unrelated to the disease.[22]

Following encouraging Phase 1 trials, in April, researchers announced they were starting Phase 2 clinical trials (called CUPID2 and SERCA-LVAD) on 250 patients[101] at several hospitals to combat heart disease. The therapy was designed to increase the levels of SERCA2, a protein in heart muscles, improving muscle function.[102] The FDA granted this a Breakthrough Therapy Designation to accelerate the trial and approval process.[103] In 2016 it was reported that no improvement was found from the CUPID 2 trial.[104]

In July researchers reported promising results for six children with two severe hereditary diseases had been treated with a partially deactivated lentivirus to replace a faulty gene and after 732 months. Three of the children had metachromatic leukodystrophy, which causes children to lose cognitive and motor skills.[105] The other children had Wiskott-Aldrich syndrome, which leaves them to open to infection, autoimmune diseases and cancer.[106] Follow up trials with gene therapy on another six children with Wiskott-Aldrich syndrome were also reported as promising.[107][108]

In October researchers reported that two children born with adenosine deaminase severe combined immunodeficiency disease (ADA-SCID) had been treated with genetically engineered stem cells 18 months previously and that their immune systems were showing signs of full recovery. Another three children were making progress.[19] In 2014 a further 18 children with ADA-SCID were cured by gene therapy.[109] ADA-SCID children have no functioning immune system and are sometimes known as "bubble children."[19]

Also in October researchers reported that they had treated six haemophilia sufferers in early 2011 using an adeno-associated virus. Over two years later all six were producing clotting factor.[19][110]

Data from three trials on Topical cystic fibrosis transmembrane conductance regulator gene therapy were reported to not support its clinical use as a mist inhaled into the lungs to treat cystic fibrosis patients with lung infections.[111]

In January researchers reported that six choroideremia patients had been treated with adeno-associated virus with a copy of REP1. Over a six-month to two-year period all had improved their sight.[112][113] By 2016, 32 patients had been treated with positive results and researchers were hopeful the treatment would be long-lasting.[16] Choroideremia is an inherited genetic eye disease with no approved treatment, leading to loss of sight.

In March researchers reported that 12 HIV patients had been treated since 2009 in a trial with a genetically engineered virus with a rare mutation (CCR5 deficiency) known to protect against HIV with promising results.[114][115]

Clinical trials of gene therapy for sickle cell disease were started in 2014[116][117] although one review failed to find any such trials.[118]

In February LentiGlobin BB305, a gene therapy treatment undergoing clinical trials for treatment of beta thalassemia gained FDA "breakthrough" status after several patients were able to forgo the frequent blood transfusions usually required to treat the disease.[119]

In March researchers delivered a recombinant gene encoding a broadly neutralizing antibody into monkeys infected with simian HIV; the monkeys' cells produced the antibody, which cleared them of HIV. The technique is named immunoprophylaxis by gene transfer (IGT). Animal tests for antibodies to ebola, malaria, influenza and hepatitis are underway.[120][121]

In March scientists, including an inventor of CRISPR, urged a worldwide moratorium on germline gene therapy, writing scientists should avoid even attempting, in lax jurisdictions, germline genome modification for clinical application in humans until the full implications are discussed among scientific and governmental organizations.[122][123][124][125]

Also in 2015 Glybera was approved for the German market.[126]

In October, researchers announced that they had treated a baby girl, Layla Richards, with an experimental treatment using donor T-cells genetically engineered using TALEN to attack cancer cells. Two months after the treatment she was still free of her cancer (a highly aggressive form of acute lymphoblastic leukaemia [ALL]). Children with highly aggressive ALL normally have a very poor prognosis and Layla's disease had been regarded as terminal before the treatment.[127]

In December, scientists of major world academies called for a moratorium on inheritable human genome edits, including those related to CRISPR-Cas9 technologies[128] but that basic research including embryo gene editing should continue.[129]

In April the Committee for Medicinal Products for Human Use of the European Medicines Agency endorsed a gene therapy treatment called Strimvelis and recommended it be approved.[130][131] This treats children born with ADA-SCID and who have no functioning immune system - sometimes called the "bubble baby" disease. This would be the second gene therapy treatment to be approved in Europe.[132]

In October, Chinese scientists reported they had started a trial to genetically modify T-cells from 10 adult patients with lung cancer and reinject the modified T-cells back into their bodies to attack the cancer cells. The T-cells had the PD-1 protein (which stops or slows the immune response) removed using CRISPR-Cas9.[133][134]

Speculated uses for gene therapy include:

Gene Therapy techniques have the potential to provide alternative treatments for those with infertility. Recently, successful experimentation on mice has proven that fertility can be restored by using the gene therapy method, CRISPR.[135] Spermatogenical stem cells from another organism were transplanted into the testes of an infertile male mouse. The stem cells re-established spermatogenesis and fertility.[136]

Athletes might adopt gene therapy technologies to improve their performance.[137]Gene doping is not known to occur, but multiple gene therapies may have such effects. Kayser et al. argue that gene doping could level the playing field if all athletes receive equal access. Critics claim that any therapeutic intervention for non-therapeutic/enhancement purposes compromises the ethical foundations of medicine and sports.[138]

Genetic engineering could be used to change physical appearance, metabolism, and even improve physical capabilities and mental faculties such as memory and intelligence. Ethical claims about germline engineering include beliefs that every fetus has a right to remain genetically unmodified, that parents hold the right to genetically modify their offspring, and that every child has the right to be born free of preventable diseases.[139][140][141] For adults, genetic engineering could be seen as another enhancement technique to add to diet, exercise, education, cosmetics and plastic surgery.[142][143] Another theorist claims that moral concerns limit but do not prohibit germline engineering.[144]

Possible regulatory schemes include a complete ban, provision to everyone, or professional self-regulation. The American Medical Associations Council on Ethical and Judicial Affairs stated that "genetic interventions to enhance traits should be considered permissible only in severely restricted situations: (1) clear and meaningful benefits to the fetus or child; (2) no trade-off with other characteristics or traits; and (3) equal access to the genetic technology, irrespective of income or other socioeconomic characteristics."[145]

As early in the history of biotechnology as 1990, there have been scientists opposed to attempts to modify the human germline using these new tools,[146] and such concerns have continued as technology progressed.[147] With the advent of new techniques like CRISPR, in March 2015 a group of scientists urged a worldwide moratorium on clinical use of gene editing technologies to edit the human genome in a way that can be inherited.[122][123][124][125] In April 2015, researchers sparked controversy when they reported results of basic research to edit the DNA of non-viable human embryos using CRISPR.[135][148]

Regulations covering genetic modification are part of general guidelines about human-involved biomedical research.

The Helsinki Declaration (Ethical Principles for Medical Research Involving Human Subjects) was amended by the World Medical Association's General Assembly in 2008. This document provides principles physicians and researchers must consider when involving humans as research subjects. The Statement on Gene Therapy Research initiated by the Human Genome Organization (HUGO) in 2001 provides a legal baseline for all countries. HUGOs document emphasizes human freedom and adherence to human rights, and offers recommendations for somatic gene therapy, including the importance of recognizing public concerns about such research.[149]

No federal legislation lays out protocols or restrictions about human genetic engineering. This subject is governed by overlapping regulations from local and federal agencies, including the Department of Health and Human Services, the FDA and NIH's Recombinant DNA Advisory Committee. Researchers seeking federal funds for an investigational new drug application, (commonly the case for somatic human genetic engineering), must obey international and federal guidelines for the protection of human subjects.[150]

NIH serves as the main gene therapy regulator for federally funded research. Privately funded research is advised to follow these regulations. NIH provides funding for research that develops or enhances genetic engineering techniques and to evaluate the ethics and quality in current research. The NIH maintains a mandatory registry of human genetic engineering research protocols that includes all federally funded projects.

An NIH advisory committee published a set of guidelines on gene manipulation.[151] The guidelines discuss lab safety as well as human test subjects and various experimental types that involve genetic changes. Several sections specifically pertain to human genetic engineering, including Section III-C-1. This section describes required review processes and other aspects when seeking approval to begin clinical research involving genetic transfer into a human patient.[152] The protocol for a gene therapy clinical trial must be approved by the NIH's Recombinant DNA Advisory Committee prior to any clinical trial beginning; this is different from any other kind of clinical trial.[151]

As with other kinds of drugs, the FDA regulates the quality and safety of gene therapy products and supervises how these products are used clinically. Therapeutic alteration of the human genome falls under the same regulatory requirements as any other medical treatment. Research involving human subjects, such as clinical trials, must be reviewed and approved by the FDA and an Institutional Review Board.[153][154]

Gene therapy is the basis for the plotline of the film I Am Legend[155] and the TV show Will Gene Therapy Change the Human Race?.[156]

More here:
Gene therapy - Wikipedia

Posted in Genetic Engineering | Comments Off on Gene therapy – Wikipedia

Free genetic engineering Essays and Papers – 123helpme

Posted: November 20, 2016 at 7:46 am

Title Length Color Rating The Effects of Genetic Engineering on Agriculture - Genetic engineering is a way in which specific genes for an animal or plant can be extracted, and reproduced to form a new animal or plant. These new organisms will express the required trait for that gene. This practice is a very controversial topic within the scientific world. It is being implemented in various areas such as agriculture even though there are many alternatives that can be found for genetic engineered crops, such as organic materials and reducing leeching of the soil. The controversy regarding this practice occurs as it is believed to contribute both negative and positive implications and dangers, not only to oneself but the environment as a whole.... [tags: Genetic Engineering ] :: 5 Works Cited 1303 words (3.7 pages) Strong Essays [preview] Pros and Cons of Genetic Engineering - Genetic Engineering is highly controversial since some people believe that genetic engineering is playing God. As this fact there is opposition to the progression of the field by people who do not see the value in genetic engineering, or they fear what genetic engineering may lead to for us as people. There is a history of discover that belongs to genetic engineering, which has led to numerous products that have emerged which have brought numerous applications to the society of the world. Though there are benefits to genetic engineering, there are also drawbacks to genetic engineering including ethical and legal issues that are dealt with in todays society in order to try and regulate the... [tags: Genetic Engineering] :: 8 Works Cited 2049 words (5.9 pages) Term Papers [preview] The Benefits of Genetic Engineering - Almost three decades ago, on July 25, 1978, Louise Brown, the first test tube baby was born (Baird 1). With this birth another controversy broke out, do humans have the right to make life. Most of the concern comes from the fear of control over the production and development of human beings. But, those who are against cloning would most likely look the other way if they needed gene therapy after receiving a grim diagnosis. There are many aspects of genetic engineering and to thoroughly understand it looking into each is absolutely necessary.... [tags: Genetic Engineering ] :: 6 Works Cited 1443 words (4.1 pages) Powerful Essays [preview] The Ethics of Genetic Engineering - The Problem Genetic engineering has been around since the 1960s although major experiments have not been really noticed until the 1990s. The science comes in different forms the two major being cloning and genetic reconstruction. Cloning is the duplicating of one organism and making an exact copy. For example in 1996 the creation of the clone sheep named Dolly the first mammal to be cloned which was a great achievement. The other form, genetic reconstruction, is used to replace genes within humans to help or enhance the life of an unborn child for a medical reason or just for the preference of a parent.... [tags: Genetic Engineering ] :: 5 Works Cited 1437 words (4.1 pages) Powerful Essays [preview] Apocalyptic Visions of Genetic Engineering - Global warming, nuclear winter, microscopic black holessociety views all these as apocalyptic phenomena resulting from the accelerating rate of discovery in the fields of science and technology. Opinions on fields like climate change and atomic weaponry certainly have a basis in scientific evidence, but many other apocalyptic reactions derive from hypothetical situations and thought experiments. To further examine public opinions on scientific fields, we can examine genetic engineering (GE). The possibilities of GE have prompted many ethicists to provide commentary on the topic, opening a dialogue between policy and experimentation in order to address topics such as genetically modified cro... [tags: Genetic Engineering] :: 7 Works Cited 2203 words (6.3 pages) Term Papers [preview] The Genetic Engineering Industry - Ever wish chocolate was healthy and could have the same nutrients and vitamins as fruit and vegetables. Food, one of three necessities of life, affects every living organism on Earth. Although some foods are disliked because of taste or health issues, recent discovery will open up new prosperities and growth in agriculture. Genetic engineering has the capability to make foods taste better, increase nutrient value, and even engineer plants to produce aids for deadly health issues. Every day the progress, understanding, and development of genetic engineering is digging deeper and with this knowledge virtually anything is possible.... [tags: Genetic Engineering ] :: 7 Works Cited 1806 words (5.2 pages) Term Papers [preview] Genetic Engineering in Humans - Author Chuck Klosterman said, The simple truth is that were all already cyborgs more or less. Our mouths are filled with silver. Our nearsighted pupils are repaired with surgical lasers. We jam diabetics full of delicious insulin. Almost 40 percent of Americans now have prosthetic limbs. We see to have no qualms about making post-birth improvements to our feeble selves. Why are we so uncomfortable with pre-birth improvement? Despite Klostermans accurate observation, there are reasons people are wearisome toward pre-birth enhancement.... [tags: Genetic Engineering ] 859 words (2.5 pages) Better Essays [preview] Genetic Engineering: The Impact of Human Manipulation - The scenes of a science fiction movie show presumably unrealistic scientific inventions. In today's world, time travel, cloning, and even light sabers are some of the countless topics that are seemingly unattainable and just ideas of the imagination. Saying that these events are feasible would be completely absurd. However, with recent scientific advancements, science fiction is now becoming more of a reality rather than a fantasy. Nevertheless, only about twenty-five years ago, genetic engineering fell into this same, idealistic category.... [tags: Genetic Engineering ] :: 6 Works Cited 1725 words (4.9 pages) Better Essays [preview] Genetic Engineering: A Major Advancement for Mankind - As the Biochemist Isaac Asimov once said, "The advancement of Genetic Engineering makes it quite conceivable that we will design our own evolutionary progress. Scientists have always thought about new ways to progress through technology in our era, and in 1946, scientists discover that Genetic material from different viruses can be combined to form a new type of virus. This was a major discovery that trickles down to the modern era of Genetics. Current scientists have pioneered new ways to decode human DNA, beating the $3 billion government-run Genome project to its goal.... [tags: Genetic Engineering] :: 10 Works Cited 973 words (2.8 pages) Strong Essays [preview] Genetic Engineering: Is the Human Race Ready? - It is incredible to see how far genetic engineering has come. Humans, plants, and any living organism can now be manipulated. Scientists have found ways to change humans before they are even born. They can remove, add, or alter genes in the human genome. Making things possible that humans (even thirty years ago) would have never imagined. Richard Hayes claims in SuperSize Your Child. that genetic engineering needs to have limitations. That genetic engineering should be used for medical purposes, but not for genetic modification that could open the door to high-tech eugenic engineering (188).... [tags: Genetic Engineering] 1455 words (4.2 pages) Powerful Essays [preview] The Dark Side of Genetic Engineering - I never knew what genetic engineering was until I watched a special on the Discovery channel. The special showed scientists forming the first perfect embryo. What was very shocking was that the scientists kept asking each other what traits this embryo should compose of. To me that was disturbing and unethical to make a living human being based on what traits the parents would want them to have. This process goes against nature just as Francis Bacon said if we would control nature, we must first obey her (Fox 193).... [tags: Genetic Engineering Essays] 1104 words (3.2 pages) Strong Essays [preview] Historical Background Of Genetic Engineering - DNA is the material that gives us our personality, our looks, and our thought processes, good or bad, DNA controls all of this. DNA full name is Deoxyribonucleic Acid. It is called that because it is missing one oxygen atom, and it is located in the nucleus. It is also in the form of an acid. DNA is made up of four subunits: Adenine, Thymine, Guanine and Cytosine. During the production of RNA, the messenger of DNA, Uracil is used instead of thymine. A small segment of this DNA is called a gene.... [tags: dna, Genetic Engineering, genes] :: 8 Works Cited 1513 words (4.3 pages) Powerful Essays [preview] Genetic Engineering Is Not Safe - Genetic engineering is the intended modification to an organisms genetic makeup. There have been no continuing studies on this topic or action so there is no telling whether or not it is harmless. Genetic engineering is not safe because scientists have no absolute knowledge about living systems. Given that, they are unable to do DNA surgery without creating mutations. Any interference on an organisms genetic makeup can cause permanent damage, hereditary defects, lack of nutritious food, or a spread of dangerous diseases.... [tags: Genetic Engineering Essays] :: 5 Works Cited 994 words (2.8 pages) Good Essays [preview] Genetic Engineering: A Step Forward - Genetic engineering (GE) refers to the technique of modification or manipulation of genes (the biological material or chemical blue print that determines a living organisms traits) from one organism to another thus giving bacteria, plants, and animals, new features. The technique of selecting the best seed or the best traits of plants has been around for centuries. Humans have learned to graft (fuse) and hybridize (cross breed) plants, creating dwarfs and other useful forms since at least 1000 B.C.... [tags: Genetic Engineering Essays] 498 words (1.4 pages) Strong Essays [preview] Benefits of Genetic Engineering - Genetic Engineering is an idea that we can ponder on quiet days. The creation of altered DNA is an enticing aspect that can greatly influence the average human life. The research of genetic engineering is an ongoing exploration that may never end. I am a supporter of a genetic engineering. There are three basic beneficial basis of genetic engineering. Those are genetically altered crops, the creation of medicines, and the creation of organs so that many lives could be saved. Genetically altered crops are very beneficial to third world countries.... [tags: Genetic Engineering, DNA, ] :: 3 Works Cited 455 words (1.3 pages) Strong Essays [preview] Understanding Genetic Engineering - What if cancer could be cured by eating a pear. Or if a crop of wheat could be developed so that it never rotted. These may sound like science fiction but they're not as strange as they first seem to be, and may even be reality in the future. Fifteen years ago who would have thought that plants could be created to be immune to pesticides or that it would be possible to create a sheep that is exactly like its parent in every physical way. And yet both of these currently exist due to genetic engineering.... [tags: Genetic Engineering ] :: 13 Works Cited 1820 words (5.2 pages) Term Papers [preview] Genetic Engineering: Annotated Bibliography - Genetic Engineering. The World Book Encyclopedia. 2008 ed. This encyclopedia was extremely helpful. In not knowing all of the exact terms and basic knowledge of genetic engineering, it helped inform any reader of all this and more. The pages that had information on genetics and genetic engineering, had detailed definitions and descriptions for all the terms and ideas. Instead of focusing more towards the future of genetic engineering, it gave numerous facts about the technology and accomplishments of today.... [tags: Annotated Bibliographies, Genetic Engineering] 879 words (2.5 pages) Strong Essays [preview] Is Genetic Engineering Superior or Appalling? - Genetic engineering has changed a lot through the years. It is now possible not to only be able to genetically engineer just plants but also animals and people, plants especially. There are many different kind of plants that have been genetically modified. Genetic engineering is not all good but it is also not all bad. Genetic Engineering will come together the more you read. Plants are not the only thing getting bigger because of genetic engineering modifying the sizes. Animals are starting to become a bigger part of genetic engineering.... [tags: genetic plants,polar tree, genetic engineering] :: 7 Works Cited 1183 words (3.4 pages) Strong Essays [preview] Genetic Engineering: The Negative Impacts of Human Manipulation - The scenes of a science fiction movie show presumably unrealistic scientific inventions. In today's world, time travel and cloning are only two of the countless topics that are seemingly unattainable ideas of the imagination. Saying that these events are within reach would be completely absurd. However, with recent scientific advancements, science fiction is now becoming more of a reality rather than a fantasy. Nevertheless, only about twenty-five years ago, genetic engineering fell into this same, idealistic category.... [tags: Genetic Engineering ] :: 6 Works Cited 1675 words (4.8 pages) Powerful Essays [preview] Genetic Engineering: Major Advancement or Major Setback? - As the Biochemist Isaac Asimov once said, "The advancement of Genetic Engineering makes it quite conceivable that we will design our own evolutionary progress. Scientists have always thought about new ways to progress through technology in this era, and in 1946, scientists discovered that Genetic material from different viruses can be combined to form a new type of virus. This was a major discovery that trickles down to the modern era of Genetics. Current scientists have pioneered new ways to decode human DNA, beating the $3 billion government-run Genome project to its goal.... [tags: Genetic Engineering ] :: 10 Works Cited 1335 words (3.8 pages) Strong Essays [preview] Human Genetic Engineering in Beneficial to Society - Even after thousands of years of evolution, the human race is not perfect: it is ravaged by disease and limited by nature. Yet, in recent times, researchers have begun to ascertain an advanced understanding of the underlying genetic code of humanity. The Human Genome Project, now complete, has provided a map of the intricacies in human DNA, allowing researchers to begin looking at the purpose of each gene. When combined with selective embryo implantation, which is used occasionally today to avoid hereditary diseases or to choose gender, genetic discoveries can become a sort of artificial evolution.... [tags: Pro Human Genetic Engineering] :: 8 Works Cited 1484 words (4.2 pages) Powerful Essays [preview] Genetic Engineering - Just imagine the scene: and newlywed wife and husband are sitting down with a catalog, browsing joyously, pointing and awing at all the different options, fantasizing about all the possibilities that could become of their future. Is this a catalog for new furniture. No. This catalog for all features, phenotype and genotype, for the child they are planning to have. It is basically a database for parents to pick and choose all aspects of their children, from the sex of the child, to looks, and even to personality traits.... [tags: Genetic Engineering] 1131 words (3.2 pages) Good Essays [preview] Genetic Engineering - Genes are, basically, the blueprints of our body which are passed down from generation to generation. Through the exploration of these inherited materials, scientists have ventured into the recent, and rather controversial, field of genetic engineering. It is described as the "artificial modification of the genetic code of a living organism", and involves the "manipulation and alteration of inborn characteristics" by humans (Lanza). Like many other issues, genetic engineering has sparked a heated debate.... [tags: Genetic Engineering ] :: 7 Works Cited 1882 words (5.4 pages) Term Papers [preview] Genetic Engineering: The End of Life as We Know It - Prior to 1982, genetic engineering was a relatively new branch of science. Today, scientists have a firm understanding of genetics and its importance to the living world. Genetic engineering allows us to influence the laws of nature in ways favorable to ourselves. Although promising in its achievements, it also has the potential for abuse. If engineering of this caliber were to be used for anything other than the advancement of the human race, the effects could be devastating. If precautions are not implemented on this science, parents might use it solely for eugenic purposes.... [tags: Genetic Engineering Essays] 773 words (2.2 pages) Better Essays [preview] Genetic Engineering: The Next Technological Leap or a Disruption to the Natural Order of Our Planet? - While walking down the produce aisle at your local grocery store, have you ever questioned where the assortment of goods came from. When asked, perhaps your first thought would likely be from a local farm or orchard. But what if I were to tell you that those very goods could in fact be from a far less obvious third choice. What if someone told you that those pretty peaches on display were meticulously grown in a laboratory to bring forth predetermined traits. As futuristic as it may sound, this type of technology is no longer science fiction but has become a new reality.... [tags: Genetic Engineering ] :: 3 Works Cited 936 words (2.7 pages) Better Essays [preview] The Need for Policy Makers to Regulate Human Genetic Engineering - Human genetic engineering (HGE), a prevalent topic for scientists in research, is the process of manipulating genes in the human genome. Potentially, scientists can use the process of HGE to alter many biological and psychological human traits by gene modification. Currently, however, there is a large deficiency in information regarding HGE and its effects to the human body; creating a need for scientists to conduct more research and tests. Because of the many unknowns involving HGE it is necessary for policy makers to regulate HGE for the use by scientists.... [tags: Human Genetic Engineering] :: 2 Works Cited 1249 words (3.6 pages) Strong Essays [preview] The Pros and Cons of Genetic Engineering - Genetic engineering is a process in which scientists transfer genes from one species to another totally unrelated species. Usually this is done in order to get one organism to produce proteins, which it would not naturally produce. The genes taken from one species, which code for a particular protein, are put into cells of another species, using a vector. This can result in the cells producing the desired protein. It is used for producing proteins which can be used by humans, such as insulin for diabetics and is also used to make organisms better at surviving, for example genetically modifying a plant so that it can survive in acidic soil.... [tags: Genetic Engineering Essays] 1054 words (3 pages) Better Essays [preview] Genetic Engineering: The Controversy of Genetic Screening - The Controversy of Genetic Screening Craig Ventor of Celera Genomics, Rockville, MD, and Francis Collins of the National Institutes of Health and Wellcome Trust, London, England, simultaneously presented the sequence of human DNA in June of 2000, accomplishing the first major endeavor of the Human Genome Project (HGP) (Ridley 2). As scientists link human characteristics to genes-segments of DNA found on one or more of the 23 human chromosomes-prospects for genetic engineering will increase dramatically.... [tags: Genetic Engineering Essays] :: 4 Works Cited 1609 words (4.6 pages) Powerful Essays [preview] An Enhanced Genotype: Ethical Issues Involved with Genetic Engineering and their Impact as Revealed by Brave New World - An Enhanced Genotype: Ethical Issues Involved with Genetic Engineering and their Impact as Revealed by Brave New World Human society always attempts to better itself through the use of technology. Thus far, as a species, we have already achieved much: mastery of electronics, flight, and space travel. However, the field in which the most progress is currently being made is Biology, specifically Genetic Engineering. In Aldous Huxleys Brave New World, humanity has taken control of reproduction and biology in the same way that we have mastered chemistry and physics.... [tags: Genetic Engineering ] :: 6 Works Cited 2288 words (6.5 pages) Term Papers [preview] The Benefits of Genetic Engineering - Outline I. Thesis statement: The benefits of genetic engineering far outweigh its potential for misuse. II. Genetic Engineering A. Definition of Genetic Engineering. (#6) B. Who invented Genetic Engineering Gregor Mendel (Christopher Lampton #7) Thomas Hunt Morgan (Christopher Lampton #7) III. Benefits of Genetic Engineering A. Genetic Screening (Laurence E. Karp #4) B. Gene Therapy (Renato Dulbecco #6) C. Cloning D. Genetic Surgery (Christopher Lampton #7) E. Benefits in Agriculture (David Pimentel and Maurizio G.... [tags: Genetic Engineering Research Papers] :: 15 Works Cited 2500 words (7.1 pages) Strong Essays [preview] The Benefits of Genetic Engineering - The selective Engineering of Genetics is invaluable to the health and happiness of humans. The importance of this issue has played second fiddle to the arguments, for and against genetic engineering. This essay will discuss the impact of genetic engineering on everyday life, for example genetic disorders, disease and how its impact on life in the world today. Although the opinions differ greatly, the benefits are substantial. Firstly, an increasing importance is being placed on the role of genetic engineering in the use of riding the incidence of genetic disorders.... [tags: Genetic Engineering Essays] :: 8 Works Cited 1176 words (3.4 pages) Strong Essays [preview] The Benefits of Genetic Engineering - What exactly is genetic engineering. A simple definition of genetic engineering is the ability to isolate DNA pieces that contain selected genes of other species(Muench 238). Genetic engineering has been the upcoming field of biology since the early nineteen seventies. The prosperous field has benefits for both the medical and also the agricultural field. The diminishing of diseases, especially congenital disorders, reduction of pollution, eradication of world hunger, and increased longevity are just some of the possibilities which scientists foresee.... [tags: Genetic Engineering Essays] 1146 words (3.3 pages) Strong Essays [preview] Genetic Engineering Is Not Ethical - For many years, genetic engineering has been a topic in heated debates. Scientists propose that genetic engineering far outweighs its risks in benefits and should be further studied. Politicians argue that genetic engineering is largely unethical, harmful, and needs to have strong limitations. Although genetic engineering may reap benefits to modern civilization, it raises questions of human ethics, morality, and the limitations we need to set to protect humanity. Though there is harsh criticism from politicians, scientists continue to press forward saying that genetic engineering is of utmost importance to help and improve society.... [tags: Genetic Engineering is Immoral ] :: 5 Works Cited 1490 words (4.3 pages) Strong Essays [preview] Is Genetic Engineering Ethically Correct? - Over the past few years, genetic engineering has come a long way from its roots. What spawned as just a project for understanding has now become quite powerful. An article written by Michael Riess aided me in gaining some knowledge of the ethical dilemmas faced in the field of genetic engineering. Suppose you and your partner both discover that you are carriers of a genetic defect known as cystic fibrosis, and the two of you are expecting a baby. Genetic screening gives you the opportunity to use antenatal diagnosis to see if the baby will have cystic fibrosis or not (Reiss).... [tags: Genetic Engineering Essays] :: 2 Works Cited 715 words (2 pages) Strong Essays [preview] The Benefits of Genetic Engineering - The engineering of deoxyribonucleic acid (DNA) is entirely new, yet genetics, as a field of science, has fascinated mankind for over 2,000 years. Man has always tried to bend nature around his will through selective breeding and other forms of practical genetics. Today, scientists have a greater understanding of genetics and its role in living organisms. Unfortunately, some people are trying to stop further studies in genetics, but the research being conducted today will serve to better mankind tomorrow.... [tags: Genetic Engineering Essays] 1109 words (3.2 pages) Strong Essays [preview] The Benefits of Genetic Engineering - Many people are envied or deprecated because of certain traits they are born with. Those that are envied are a select few, which in turn is why they are envied. When one child in a nursery has a toy, he is coveted by all the other children in the nursery. He will be idolized, and nearly every child will want to be his friend. However, there will also those that want the toy for themselves. The children that are jealous will do whatever they can to get the toy. The jealous children often resort to violence, and this is true in all aspects of life.... [tags: Genetic Engineering Essays] 975 words (2.8 pages) Strong Essays [preview] Genetic Engineering and the Media - Genetic engineering and its related fields have stimulated an extremely controversial scientific debate about cloning for the last decade. With such a wide range of public opinions, it is hard to find any middle ground. Some feel that improving the genes of future children will help mankind make a major evolutionary step forward. Others agree that there could be dangerous unforeseen consequences in our genetic futures if we proceed with such endeavors. A third group warns that the expense of genetic enhancement will further separate the wealthy from the poor and create a super race. Popular magazines and the Internet are two of the major arenas in which this debate has been hotly cont... [tags: Genetic Engineering Essays] :: 21 Works Cited 1731 words (4.9 pages) Powerful Essays [preview] The FDA Should Prohibit Genetic Engineering - Abstract: Recent developments in genomic research have enabled humans to manipulate the genes of living organisms with genetic engineering. Scientists have used this momentous technology in environmental and most recently, agricultural spheres. However, the United States Food and Drug Administration (FDA) does not require that genetically altered foods be labeled as such. As a result, there is no protection against humans' ability to construct organisms that nature never intended to exist and to threaten nature's carefully balanced environment. Is it ethically responsible for the government to allow scientists to continue with these advances if they do not understand their consequences.... [tags: Genetic Engineering, Genetic Ethics] :: 10 Works Cited 2439 words (7 pages) Powerful Essays [preview] Genetic Engineering is Immoral - Genetic engineering gives the power to change many aspects of nature and could result in a lot of life-saving and preventative treatments. Today, scientists have a greater understanding of genetics and its role in living organisms. However, if this power is misused, the damage could be very great. Therefore, although genetic engineering is a field that should be explored, it needs to be strictly regulated and tested before being put into widespread use. Genetic engineering has also, opened the door way to biological solutions for world problems, as well as aid for body malfunctions.... [tags: Genetic Engineering Essays] 423 words (1.2 pages) Strong Essays [preview] Genetic Engineering is Unethical - Just as the success of a corporate body in making money need not set the human condition ahead, neither does every scientific advance automatically make our lives more meaningful'; (Wald 45). These words were spoken by a Nobel Prize winning biologist and Harvard professor, George Wald, in a lecture given in 1976 on the Dangers of Genetic Engineering. This quotation states that incredible inventions, such as genetic engineering, are not always beneficial to society. Genetic engineering is altering the genetic material of cells and/or organisms in order to make them capable of making new substances or performing new functions'; (Wald 45).... [tags: Genetic Engineering is Immoral] :: 3 Works Cited 1141 words (3.3 pages) Better Essays [preview] Genetic Engineering is Unethical - Genetic engineering is a technology that has been created to alter DNA of different species to try and make them more improved. This essay will discuss the eugenics, the religious point of view about genetic engineering, genetically modified food and the genetic screening of embryos. In this essay it will be said wether genetic engineering is ethical or unethical. During 1924 Hitler said that everyone needs to be blond hair, blue eyes and white. This is known as Eugenics, thanks to a new science known as biotechnology in a few decades.... [tags: Genetic Engineering Essays] 492 words (1.4 pages) Strong Essays [preview] Genetic Engineering: Playing God - Current technology has made what once seemed impossible, mapping the human genome, a reality within the next decade. What began over forty years ago with the discovery of the basic structure of DNA has evolved into the Human Genome Project. This is a fifteen-year, three billion dollar effort to sequence the entire human genetic code. The Project, under the direction of the U.S. National Institute of Health and the department of Energy is ahead of schedule in mapping what makes up an individual's genetic imprint.... [tags: Genetic Engineering Essays] 634 words (1.8 pages) Strong Essays [preview] Genetic Engineering: Playing God - Regenerating extinct species, engineering babies that are born without vital body organs, this is what the use of genetic engineering brings to the world. In Greek myth, an chimera was a part lion, part goat, part dragon that lived in Lycia; in real life, its an animal customized with genes of different species. In reality, it could be a human-animal mixture that could result in horror for the scientific community. In myth the chimera was taken down by the warrior Bellerophon, the biotech version faces platoons of lawyers, bioethicists, and biologists (Hager).... [tags: Genetic Engineering Essays] :: 8 Works Cited 1804 words (5.2 pages) Strong Essays [preview] Genetic Engineering Research Paper - I. Introduction In the past three decades, scientists have learned how to mix and match characteristics among unrelated creatures by moving genes from one creature to another. This is called genetic engineering. Genetic Engineering is prematurely applied to food production. There are estimates that food output must increase by 60 percent over the next 25 years to keep up with demand. Thus, the result of scientist genetically altering plants for more consumption. The two most common methods for gene transfer are biological and electromechanical.... [tags: Science Biology Genetic Engineering Essays] :: 3 Works Cited 1347 words (3.8 pages) Strong Essays [preview] Human Genetic Engineering: Unnatural Selection - Introduction Technology has a significant influence across the world, as it has become a fast growing field. Modern biotechnology has been in the major forefront of this influence. From the discovery of DNA to the cloning of various animals, the study of genetic engineering has changed the way society views life. However, does genetic engineering have the capacity to influence the world to its best abilities. Products, which are genetically engineered, may cause severe negative effects on our society.... [tags: Genetic Engineering Essays] :: 3 Works Cited 1509 words (4.3 pages) Strong Essays [preview] Genetic Engineering - At the Roslin Institute in Edinburgh, Scotland, Dr. Keith Campbell, director of embryology at PPL therapeutics in Roslin, and his colleague Dr. Ian Wilmut worked together on a project to clone a sheep, Dolly, from adult cells. On February 22, 1997, they finally succeeded. Dolly was the only lamb born from 277 fusions of oocytes with udder cells. Wilmut says there were so many failures because it is difficult to ensure that the empty oocytes and the donor cell are at the same stage of the cell division cycle.To clone Dolly, basically scientists took an unfertilized egg cell, removed the nucleus, replaced it with cells taken from the organism to be cloned, put it into an empty egg cell which... [tags: Genetic Engineering Essays] 1446 words (4.1 pages) Strong Essays [preview] Genetic Engineering: Our Key to a Better World - What is genetic engineering one might ask and why is there so much moral controversy surrounding the topic. Genetic engineering as defined by Pete Moore, "is the name given to a wide variety of techniques that have one thing in common: they all allow the biologist to take a gene from one cell and insert it into another" (SS1). Such techniques included in genetic engineering (both "good" and "bad") are, genetic screening both during the fetal stage and later in life, gene therapy, sex selection in fetuses, and cloning.... [tags: Genetic Engineering Essays] :: 3 Works Cited 1117 words (3.2 pages) Better Essays [preview] Genetic Engineering and Cryonic Freezing: A Modern Frankenstein? - Genetic Engineering and Cryonic Freezing: A Modern Frankenstein. In Mary Shelley's Frankenstein, a new being was artificially created using the parts of others. That topic thus examines the ethics of "playing God" and, though written in 1818, it is still a relevant issue today. Genetic engineering and cryogenic freezing are two current technologies related to the theme in the novel of science transcending the limits of what humans can and should do. Genetic engineering is widely used today.... [tags: Genetic Engineering Essay Examples] :: 5 Works Cited 1507 words (4.3 pages) Powerful Essays [preview] Genetic Engineering: The Tremendous Benefits Outweigh the Risks - Wouldn't it be great to improve health care, improve agriculture, and improve our quality of life. Genetic engineering is already accomplishing those things, and has the potential to accomplish much more. Genetic engineering, also referred to as biotechnology, is a fairly new science where the genes of an organism are modified to change the features of an organism or group of organisms. Genes are found in the DNA (deoxyribonucleic acid) of an organism, and each gene controls a specific trait of an organism.... [tags: Genetic Engineering Essay Examples] :: 7 Works Cited 2253 words (6.4 pages) Powerful Essays [preview] Genetic Engineering Brings More Harm Than Good - Until the recent demise of the Soviet Union, we lived under the daily threat of nuclear holocaust extinguishing human life and the entire biosphere. Now it looks more likely that total destruction will be averted, and that widespread, but not universally fatal, damage will continue to occur from radiation accidents from power plants, aging nuclear submarines, and perhaps the limited use of tactical nuclear weapons by governments or terrorists. What has gone largely unnoticed is the unprecedented lethal threat of genetic engineering to life on the planet.... [tags: Genetic Engineering Essays] 1953 words (5.6 pages) Strong Essays [preview] Genetic Engineering New Teeth - The article I read was about some scientists that were able to grow teeth inside rats bodies. This project was led by Pamela C. Yelick, a scientist for Forsyth Institute, and the project was conducted in Massachusetts. Joseph P. Vacanti, a tissue engineer at Massachusetts General Hospital, and Yelick had the idea for the experiment. Vacanti had previously worked with rats and he found that cells will naturally organize themselves into tissues and other complex structures if they are placed in the right environment.... [tags: Genetic Engineering Essays] 736 words (2.1 pages) Strong Essays [preview] Ethics of Human Cloning and Genetic Engineering - INTRODUCTION When the Roslin Institute's first sheep cloning work was announced in March 1996 the papers were full of speculation about its long-term implications. Because of this discovery, the medias attention has focused mainly on discussion of the possibility, of cloning humans. In doing so, it has missed the much more immediate impact of this work on how we use animals. It's not certain this would really lead to flocks of cloned lambs in the fields of rural America, or clinically reproducible cuts of meat on the supermarket shelves.... [tags: Genetic Engineering Essays] :: 9 Works Cited 1845 words (5.3 pages) Strong Essays [preview] We Must Educate Ourselves Before Passing Laws Restricting Cloning and Genetic Engineering - Biotechnology and genetic engineering involve the cloning of animal cells and organisms, but they also involve the alteration of an organism in an effort to make it more perfect, whether it is a crop, an animal, or even a human being. Obviously the cloning of humans or the cloning of human cells is much different than the cloning of genetically superior livestock or a better quality, higher yielding food crop, and people throughout the world realize this. The cloning of human beings has become one of the worst fears in our society today and for that reason many laws have been passed throughout European countries and North America in an effort to ban human cloning.... [tags: Genetic Engineering Essays] :: 4 Works Cited 1937 words (5.5 pages) Powerful Essays [preview] The Benefits of Human Genetic Engineering - Pre-implantation genetic diagnosis is a revolutionary procedure that utilizes in vitro fertilization to implant a healthy egg cell into the mothers uterus after it is screened for mutations or other abnormalities. That way, only healthy eggs can develop to term and become beautiful, bouncing boys or girls. Designer babies have a bright future in the face of science because they are genetically engineered to be: disease free; viable donors for a sibling or parent; and with optional elimination of any severe cosmetic disorders that might develop,without risk to human diversity in the future.... [tags: Pre-implantation genetic diagnosis, PGD] :: 6 Works Cited 1650 words (4.7 pages) Powerful Essays [preview] Genetic Engineering The Perfect Child - Modern society has an unquestionable preoccupation with perfection. Indulging in our vanities with things such as plastic surgery, veneers, botox, collagen, hair dye, and so on, have become a part of the socially acceptable norm. People do these things, and more, in an attempt to become their ideal selves. However, many are taking these practices to a completely new extreme, and are not stopping at just altering their own physical characteristics. With recent advances in medical science and technology, couples are now able to genetically modify embryos to create their ideal children.... [tags: Pre-Implantation Genetic Diagnosis] :: 2 Works Cited 1022 words (2.9 pages) Strong Essays [preview] The Morals and Ethics of Genetic Engineering - Introduction Widely considered a revolutionary scientific breakthrough, genetic engineering has been on a path toward changing the world since its introduction in 1973 by Stanley Cohen and Herbert Boyer (What). However, as genetic engineering slowly permeates the lives of humanity, the morals and ethics behind what are now common practices are entering public attention, and as a culture we are left to question whether the change brought on by such a discovery bring benefits and positive change, or damage and destruction.... [tags: genetics, theology, bioethics, DNA, GMOs] :: 13 Works Cited 3322 words (9.5 pages) Research Papers [preview] The Human Genetic Engineering Debate - Science is moving forward at an increasing rate every day. Just in the past decade, there have been numerous new discoveries in astronomy, chemistry, geology, paleontology, and many more scientific fields. However, some of the fastest growing subjects are in the field of biological sciences, more specifically genetics. Over the past twenty years a new genetic science known as genetic engineering has come to prominence. Genetic engineering is the direct manipulation of an organisms genome using biotechnology, including a humans genome.... [tags: Genetics, Science Ethics] :: 9 Works Cited 1838 words (5.3 pages) Better Essays [preview] Genetic Engineering in the Modern World - Advances in biotechnology can be looked at two ways; both, positive and negative. People can also differ in what would qualify as a positive and negative way. Some may think that tinkering with Deoxyribonucleic acid also know as DNA, should not be allowed at all for any reason. Others may believe that manipulating human DNA can have many different beneficial outcomes. Biotechnology and genetic engineering can be looked at in two very different ways; can either be misused or unethical or it can be beneficial, ethical, and used for the better kind.... [tags: biotechnology, DNA, abortion] :: 1 Works Cited 966 words (2.8 pages) Better Essays [preview] Genetic Engineering and the Pursuit of Perfection - Research Paper Rough Draft In the year 2050, a young boy nervously rehearses what hes going to say as he approaches the cheerleader hes been too nervous to approach for the past month. But as he draws near, a jock pushes his books out of his hands. Hes teased, being the school wimp. They call him names like undesirable, god-child, and in-valid. Of course nobody cares for a less-than-perfect child whose genetic makeup was left to fate. With the introduction of genetic engineering into society, people like this young boy simply have no hope for competing against the likes of the genetically reimagined, perfect jock, people engineered to be unflawed.... [tags: Perfection, Body Image, Technology] :: 10 Works Cited 1898 words (5.4 pages) Powerful Essays [preview] Genetic Engineering: Pros and Cons - Our world has finally begun its long-predicted descent into the depths of chaos. We may not yet realize it, but more and more problems plague the very state of our humanity with each passing day, such as cancer, famine, genetic disorders, and social elitism. It seems as though there is little hope, although a new solution has finally emerged, in the form of genetic engineering. It is apparent, however, that currently we cannot proceed, because while there are an abundant amount of advantages to genetic engineering, it is not a utopian process; criticism includes its practicality, theological implications, and changes in modern social structure.... [tags: Eugenics, Ethics] :: 5 Works Cited 1212 words (3.5 pages) Strong Essays [preview] Is Genetic Engineering Ethically Right? - Described at its most simple, ethics can be described as a socially constructed set of behaviours and beliefs deemed either acceptable or unacceptable by the vast majority of people. Ethical beliefs can vary somewhat from person to person and are ever changing and malleable (www.ncbi.nlm.gov/pubmed/15289521). There are three main ethical theories used by present day philosophers; these are Meta-ethics, Normative ethics and Applied ethics. Meta-ethics focuses on the nature of moral judgement and the foundation of ethical principles.... [tags: DNA, gene, diabetis] :: 10 Works Cited 1191 words (3.4 pages) Strong Essays [preview] Genetic Engineering and the Public - Genetic Engineering and the Publics Uses of Genetic Engineering Opinions about genetic engineering range from disgust to awe. These opinions may also depend on what type of animal is being genetically manipulated, how such manipulation is being done, and for what reasons. In California, pet fish that have been genetically altered to fluoresce (glofish) have been restricted for sale.[1] Yet, for the rest of the United States these fish are found in several species, varieties and morphs. In California, Commissioner of Californias Fish and Game, Sam Schuchat, felt that there was a difference in genetic modification depending on the use of the product made.[2] The use of genetic engineering f... [tags: Stake Holders, Science, Dialogue] :: 6 Works Cited 877 words (2.5 pages) Better Essays [preview] Genetic Engineering: A Good Thing? - Today there are many definitions of Genetic Engineering, such as Genetic Engineering is a laboratory technique used by scientists to change the DNA of living organisms (Kowalski) and Genetic Engineering refers to the modification or manipulation of a living organisms genes (Genetic). No matter the wording all definitions of genetic engineering refers to somehow changing an organisms genetic identity. Many people today support genetic engineering because it has many potential benefits for today's society; however, it also has many potential threats associated with it.... [tags: argumentative, persuasive, informative] :: 19 Works Cited 1928 words (5.5 pages) Powerful Essays [preview] Genetic Engineering and its Drawbacks - In the past few years, there have been numerous technological advances, one of them being genetic engineering. Scientists are experimenting with genes and animals to create everything from a Day-Glo pet fish to a pig whose liver could be used in a liver transplant for humans. Scientists argue that genetic engineering can be used to test medicinal products without putting humans at risk, to battle diseases and to make a body with a stronger immune system, amongst many other reasons, which they claim are to improve the outcome of the human race.... [tags: gene, transplant, animal testing] :: 9 Works Cited 911 words (2.6 pages) Better Essays [preview] The Perfect Child: Genetic Engineering - Have you ever wondered what it would be like if you could produce the perfect child. You picked their eye color, hair color, body type, even intelligence level. Instead of waiting nine months to see what your child looks like; you will already know because you chose their outer appearance. Improvements in science, has given way to the idea of allowing people to choose their offsprings physical attributes. This new concept is known as designer babies. A designer baby according to the oxford dictionary is a baby whose genetic makeup has been artificially selected by genetic engineering, combined with in vitro fertilization to ensure the presence or absence of particular genes or characteris... [tags: Designer Babies, Stem Cells] :: 5 Works Cited 899 words (2.6 pages) Better Essays [preview] Cons of Genetic Modification of Plants - In our everyday lives we have a substantial need for food. Everyone on planet earth needs food to survive from day to day, so engineers have begun mutating plants and crops to create a better source of nutrition to the population. Scientists are pushing the boundaries in order to create the most bountiful crops and, in turn, healthier people. Imagine what could happen if there were larger harvests, more succulent fruits and nutritious vegetables. Our imagination can run wild with the endless possibilities of genetic alteration of food.... [tags: Genetic Engineering ] :: 5 Works Cited 1011 words (2.9 pages) Strong Essays [preview] Germline Engineering and Reprogenetic Technologies - Modern technologies are constantly advancing in a multitude of ways to the degree that scientists have gained enough knowledgeable about the human genome to be able to find specific genes during the embryonic stage of reproduction. Scientists have already begun to use this knowledge to allow parents the ability to select the sex of their child and screen for genetic diseases via preimplantation genetic diagnosis (PGD) with in vitro fertilization (IVF). Sex-selection has already created world-wide discussion regarding the ethics of such a situation.... [tags: Genetic Engineering ] :: 4 Works Cited 2055 words (5.9 pages) Term Papers [preview] Genetic Engineering and Experimentation - ... However, Ill be using it in the context that it is the experimentation of genetic engineering to see if its safe for the public. While you might think genetic engineering/experimentation is all fun and games while youre having your genes modified to make you smarter, or prettier, or something like that, there are consequences and dangers that can come with that modification. Then again, once perfected, genetic engineering could do a lot of good for humanity and society in general. Eliminate diseases, fix mental and psychological disabilities, maybe even (and semi-hopefully) keep people from being outright stupid.... [tags: Science, Controversy] :: 4 Works Cited 880 words (2.5 pages) Better Essays [preview] The Genetic Engineering Debate - In recent discussions of genetic engineering, a controversial issue has been whether genetic engineering is ethical or not. In The Person, the Soul, and Genetic Engineering, JC Polkinghorne discusses about the moral status of the very early embryo and therapeutic cloning. J. H. Brookes article Commentary on: The Person, the Soul, and Genetic Engineering comments and state opinions that counter Polkinghornes article. On the other hand John Harriss Goodbye Dolly? The Ethics of Human Cloning examines the possible uses and abuses of human cloning and draw out the principal ethical dimensions, both of what might be done and its meaning, and of public and official response (353).... [tags: Ethical Dilemma, Embryos With Dignity] :: 4 Works Cited 1403 words (4 pages) Powerful Essays [preview] Ethics of Genetic Modification Technology - Modern society is on the verge of a biotechnological revolution: the foods we eat no longer serve simply to feed us, but to feed entire nations, to withstand natural disasters, and to deliver preventative vaccination. Much of this technology exists due to the rapid development of genetic modification, and todays genetically modified crops are only the tip of the proverbial iceberg. Says Robert T. Fraley, chief technology officer for biotech giant Monsanto, Its like computers in the 1960s. We are just at the beginning of the explosion of technology we are going to see." Biotechnologys discontents are numerous and furious, declaring the efforts of corporations of Monsanto to be dangerous... [tags: Genetic Engineering] 776 words (2.2 pages) Better Essays [preview] Xerosotmia and genetic engineering - All around the globe, predominantly in the United States and in Europe, there are technological advances in science that affects the way people live. In recent years, genetically modified organisms (GMOs) have replaced peoples diet with genetically altered foods, which has affected human health. In a broad view, GMOs are created by splicing genes of different species that are combined through genetic engineering, consequently improving the resulting organism. Large corporations who choose to use Xerosotmia i i make larger profits with less time and effort involved (ABNE).... [tags: biology, genetically modified organisms] :: 4 Works Cited 1309 words (3.7 pages) Powerful Essays [preview] The Dangers of Genetic Engineering - Genetically manipulating genes to create certain traits in a human embryo is impossible at this point. Perhaps it will never happen. It is not inevitable in the long run, as some scientists pragmatically point out. (Embgen). It is, however, something that dominates modern day discussion concerning genetics and therefore must be addressed with care and consideration. There are many ways that gene manipulation could come about. Advances in spermatogenesis as well as the field of assisted reproductive technology, as seen in In Vitro Fertilization clinics, point toward methods that could house the systematic alteration of genetic information in reproductive cells. Transpl... [tags: Genetic Manipulation Essays] :: 5 Works Cited 1033 words (3 pages) Strong Essays [preview] Engineering the Perfect Human - For centuries, mankind has been fascinated by the idea of perfection. In recent decades, the issue has been raised regarding the perfect human and whether scientists are able to engineer and create this. Attempts have been made in the past to engineer this said perfect human, through eugenics and scientific racism, but until now, these attempts have been ineffective. Only now, with modern technology, are scientists able to make more significant progress in altering the human genome to the produce desired characteristics of perfection.... [tags: Genetic Engineering ] :: 21 Works Cited 1831 words (5.2 pages) Term Papers [preview] Can Genetic Modification Benefit Humanity? - Throughout the course of human history, new technological advancements have always created opposing views, and conflict between the different groups that hold them. Today, one of the greatest technological controversies is over the morals and practicality of genetically modifying crops and animals. Reasons for doing so vary from making them more nutritious to making plants more bountiful to allowing organisms to benefit humans in ways never before possible. Genetic engineering is a process in which genes within the DNA of one organism are removed and placed into the DNA of another, a reshuffling of genesfrom one species to another (Steinbrecher qtd.... [tags: Genetic Engineering] 1676 words (4.8 pages) Powerful Essays [preview] Genetic Engineering - In the field of animal and human genetic engineering there is much more speculation, than fact, because very little has actually been tested in the real world. Firstly, theres a big question mark over safety of genetic engineering. In addition, genetic engineering can cause greater problems than that what we have today. Moreover, we can create a injustice world between Designer vs Non-designer children. Furthermore, genetic engineering is a type of murder because of the process of genetically modifying a baby.... [tags: designer babies, perfect baby] :: 5 Works Cited 911 words (2.6 pages) Better Essays [preview] Genetic Engineering - Imagine a world where diseases can be found and prevented before they happen. This would be a future possibility if genetic engineering became more advanced. Genetic engineering is when parts of DNA are spliced into another piece of DNA which give new traits to the organism containing the DNA. Through continued research in the field of genetics, techniques such as mapping genomes and splicing DNA can be used beneficially to improve on existing organisms and their traits. To help understand genetic engineering, it is important to understand its history.... [tags: Cloning] :: 4 Works Cited 894 words (2.6 pages) Better Essays [preview] Genetic Engineering - In the 21st century, times are changing. Everyday objects are becoming perfect with alterations to their system. These alterations are not only occurring on man-made objects, but also on natural organisms, such as newborn babies. Science has come a long way to being able to have the capability to alter pre-born babies to a parents desire. There are four arguments that can be considered when discussing this topic, including nature and three others. While many scientific minds are all for creating perfection in a child, many different groups of minds are arguing this act against nature should be abolished from scientists minds.... [tags: Ethics] 888 words (2.5 pages) Better Essays [preview] Genetic Engineering - I, as a Christian, believe that the traits of a child are a blessing to a parent in one-way or another. Although I hold this true, I actually wouldnt mind being able to design my own baby. I mean, I could root out all of the bad traits, and add the ones I want. I would make my child a girl with olive skin, brown hair, bright green eyes, and to have the dancing feet of Fosse, the facial expressions of Liz Taylor, and the vocal chords of Lea Michelle. I want her to be a star of the screen or stage.... [tags: controversy, genes, physical traits, flaws] :: 3 Works Cited 890 words (2.5 pages) Better Essays [preview] Genetic Engineering - Moore's law, the statement that technologies will double every two years is a very thought-provoking inception for technologist and scientist (Moore's Law par.1). Numerous people are thrilled about this commandment while others are petrified. Why an individual might be troubled by technology one might inquire. Well there are many arguments that claim that technology is contrary to itself, nature, and humans. The unpretentious fact is technology is cohesive within the humanoid existence and will linger as time travels on.... [tags: genetically modified foods] :: 13 Works Cited 1461 words (4.2 pages) Powerful Essays [preview] Human Genetic Engineering: Dreams and Nightmares - Technological breakthroughs and advancements have occurred so rapidly since the dawn of the information age, that one often overlooks the great power humanity holds over the building blocks of life itself. While our understanding and mapping of Deoxyribonucleic acid (DNA) sequences has been slow coming since Friedrich Mieschers isolation of the double-helix shaped molecule, efforts in recent decades to map the human genome have opened many doors to the potential manipulation of lifes basic elements.... [tags: human genome, human genetics, cloning] :: 7 Works Cited 1162 words (3.3 pages) Strong Essays [preview]

Original post:
Free genetic engineering Essays and Papers - 123helpme

Posted in Genetic Engineering | Comments Off on Free genetic engineering Essays and Papers – 123helpme

Public Outreach | Stem Cell and Regenerative Medicine Center

Posted: November 20, 2016 at 7:45 am

Our Stem Cell Learning Lab was made possible through a grant from the Ira and Ineva Reilly Baldwin Wisconsin Idea Endowment. Through this effort, we seek to build a greater understanding of stem cell research and regenerative medicine into school and community science outreach programs in Wisconsin. Our UW-Madison stem cell outreach labs are among the very few in the country and continue to place Madison at the forefront of stem cell research education and science education. We hope teachers will be able to take advantage of our opportunities and provide more of these unique experiences to their students.

Through this hands-on experience, either in our lab at the Biotechnology Center or at schools and science fairs, learners use the same equipment and methods stem cell researchers use to prepare and grow their cells. Our participants, however, use realistic cell and media substitutes due to biosafety and contamination concerns in public settings. To help your visit run smoothly, please contact the UW-Madison Campus Visit Program.

Our outreach programs are also part of many existing UW-Madison science programs, including Science Expeditions, Science Olympiad, the Wisconsin Science Festival, Grandparents University and UW Day at the Wisconsin State Fair. Our Stem Cell Learning Lab is a collaboration among the Stem Cell and Regenerative Medicine Center, Biotechnology Center,WiCell, Wisconsin National Primate Research Center, Student Society for Stem Cell Research(SSSCR), the Wisconsin Stem Cell Roundtable(WiSCR), and Morgridge Outreach Experiences.

Since 2010, our stem cell outreach programs have reached more than 35,000 learners.

Continued here:
Public Outreach | Stem Cell and Regenerative Medicine Center

Posted in Wisconsin Stem Cells | Comments Off on Public Outreach | Stem Cell and Regenerative Medicine Center

Stem cells | | News | UW-Madison

Posted: November 20, 2016 at 7:45 am

July 14, 2014

The ability to reliably and safely make in the laboratory all of the different types of cells in human blood is one key step closer to reality. Writing today (July 14, 2014) in the journal Nature Communications, a group led by University of WisconsinMadison stem cell researcher Igor Slukvin reports the discovery of two genetic programs responsible for taking blank-slate stem cells and turning them into both red and the array of white cells that make up human blood.

World stem cell leaders will converge on Promega's BioPharmaceutical Technology Center in Fitchburg on April 30 for the 9th Annual Wisconsin Stem Cell Symposium: From Stem Cells to Blood.

Desperate patients are easy prey for unscrupulous clinics offering untested and risky stem cell treatments, says law and bioethics Professor Alta Charo of the University of WisconsinMadison, who is studying "stem cell tourism."

As stem cells continue their gradual transition from the lab to the clinic, a research group at the University of WisconsinMadison has discovered a new way to make large concentrations of skeletal muscle cells and muscle progenitors from human stem cells.

A team of University of WisconsinMadison researchers has induced human embryonic stem cells (hESC) to differentiate toward pure-population, mature heart muscle cells, or cardiomyocytes.

A team of engineers at the University of WisconsinMadison has created a process to improve the creation of synthetic neural stem cells for use in central nervous system research.

University of Wisconsin School of Medicine and Public Health (SMPH) researchers have discovered a very early regulatory event that controls the production of blood stem cells and the adult blood system.

With last Friday's retirement of longtime University Research Park Director Mark Bugher, associate director Greg Hyer is assuming the role of interim director of the successful, 260-acre park on the West Side of Madison.

Developing a new drug takes enormous amounts of time, money and skill, but the bar is even higher for a promising stem-cell therapy. Many types of cells derived from these ultra-flexible parent cells are moving toward the market, but the very quality that makes stem cells so valuable also makes them a difficult source of therapeutics.

What if you could travel back in time 3 billion years, and take a breath? What would earths air smell like? Deeply stinky, according to Brooke Norsted, an outreach specialist for the University of WisconsinMadison Geology Museum.

Rebecca Blank arriving, Kevin Reilly leaving. Budget cuts and tuition freezes. Even if you were vacationing and unplugged over the summer, it was hard to miss these headlines. But you can be excused for not being on top of everything that happened on campus while you were away.

Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from the Morgridge Institute for Research and Northwestern University have created an efficient way to target and repair defective genes.

Many scientists use animals to model human diseases. Mice can be obese or display symptoms of Parkinson's disease. Rats get Alzheimer's and diabetes. But animal models are seldom perfect, and so scientists are looking at a relatively new type of stem cell, called the induced pluripotent stem cell (iPS cell), that can be grown into specialized cells that become useful models for human disease.

MADISON, Wis. Transplantation of human stem cells in an experiment conducted at the University of WisconsinMadison improved survival and muscle function in rats used to model ALS, a nerve disease that destroys nerve control of muscles, causing death by respiratory failure.

In new research published this week, Anita Bhattacharyya, a neuroscientist at the Waisman Center at the University of WisconsinMadison, reports on brain cells that were grown from skin cells of individuals with Down syndrome.

The Greater Milwaukee Foundation has chosen two University of WisconsinMadison researchers for 2013 Shaw Scientist Awards.

A University of WisconsinMadison research group has converted skin cells from people and monkeys into a cell that can form a wide variety of nervous-system cells - without passing through the do-it-all stage called the induced pluripotent stem cell, or iPSC.

The drug trial is not off to an auspicious start. The cells are not cooperating.

For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.

When it comes to delivering genes to living human tissue, the odds of success come down the molecule. The entire therapy - including the tools used to bring new genetic material into a cell - must have predictable effects.

View post:
Stem cells | | News | UW-Madison

Posted in Wisconsin Stem Cells | Comments Off on Stem cells | | News | UW-Madison

Page 1,691«..1020..1,6901,6911,6921,693..1,7001,710..»